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Children who attend day-care centers run all increased risk ofexposure to 
the highly contagious bacterium Baemophilus influenzae type b (Bib), a 
common cause ofmeningitis - a severe infection ofbrain and spinal cord 
membranes. Afortunate meningitis recoverer, Matthew Martin (right), 
plays at a St. Louis area day-care center with Andrew Bums, a recent par­
ticipant in clinical trials for a new vaccine against Bib directed by Dan 
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Brain damage associated with Alzheimer's disease, 
Huntington's chorea, epilepsy and other well known 
neurological disorders may be the result of a neurotrans­
mitter called glutamate that also is a potential toxin. 
Why .Johnny Can't Grow 
But Justin Can 
It's not easy being short. Clinical trials of human growth 
hormone are giving School of Medicine researchers 
valuable insights into the mechanisms that govern growth. 
AIDS Against Itself' 
Together with Robert C. Gallo at the National Cancer 
Institute, Lee Ratner has developed two mutant forms 
of the AIDS virus that may be used in the future to 
"vaccinate" patients already infected with AIDS, as well 
as to learn more about how this deadly virus cripples 
immune cells. 
Henrv Sehwartz's Constellation of 
Fortu"itous Events 
Outlook profiles one of the most esteemed neurosUf­
geons in the world, reflecting on his research contribu­
tions and his creation of the renowned neurosurgery 
training program at Washington University. 
Newsbriejo; 2 
AIUlnni Report: 
Alumni Usher in New Loan Program 27 
Class !Votes :10 
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P <ltti M. Nem<!th, Ph ,D., associat<! research pro­ks. or of neurology amI 
of anatomy and neurobiology, 
has been awarded more than 
~526,OOO in two grams from 
the Nationallnstitlltes of 
Health _ 
The first awa rd is from the 
National Jn~titute of Neurology 
ami Conn.tlIniCalivc Disorders 
~md Stroke and will fund a 
project on the biochemistry 
and physiology of single axons 
and the set of muscle filxrs 
they simulate_Nemeth and her 
tcam have developed a tech­
nique tor measuring energy 
metabolism, anatomical 
arrangell1entllnd physiologkal 
properties of these mdividual 
"motor un its_" The technique 
enables Neill th to compare 
prec isely the biochemical amI 
physical make-up of rou de 
and the physiological charac­
teristics of its nerve. 
The second award is from 
the National Institute of Ar­
thritis. Diabetes. Digestive and 
Kidney Diseases tiJr a study 01­
neural influences on the bio­
chemistry ot single muscle 
fiber -_In thl research, Nemeth 
tests the extent to whieh neural 
and n In-ncural factors - such 
as hormonal factor, - affect 
muscle during development. 
anu how fully mature llIuscles 
can be aJtered hy long-teml 
exercise or by programmed 
contrac tions induced with 
artificictl stimulation _ 
Gregory A. Grant, Ph.D., assistant professor ofbiochemistry 11lld 
medicine, explaills the finer points ofthe protein chemistry lab's 
new peptide synthesizer to Carl Friedm, Ph .D. 
. '( w I't-'ptid.· 
S, IInl('~izt'-r 
$140,000 gift from the 
Whitaker haritable 
Foundation has enabled 
the Depllrtmcnt of Biological 
Chemistry to purchase a new 
peptide synthesi7er for its prf}-­
tein sequencing facility. 
Serving as a companion 
instrument to the apor phase 
protein sequencing system. 
whieh was purChased last year 
from an earlier Whitaker foun­
dation gift. the peptide synthe­
sizer is expected to open up 
many research possibilities at 
Washington University, <.Iccord­
ing to Carl Frieden. Ph _D .. 
prorcs~or anll interi m heau of 
the tlepartl1lcnL 
The instrument will be 
e~pecial ly u~eful in Friellen's 
work, which wa<; recently 
awarded di<;tinguished MERIT 
status by the NatIOnal Institute 
of Diabetes and Digestive 
Kidney Diseases_ Such designa­
tion provides a few outstanding 
invest igato~ with long-tem1 
~lable support. allowing them 
to continue their investigations 
without many of the adminis­
trative burdens a! socialed with 
the preparation and suhmission 
of grant application~_ 
"With this new instrument, 
we can synthesi7.e pcptides 
against which antibodies could 
be prepared and targeted to 
specific malignant cells and not 
to other cells," Frieden say. _ 
The new instrument should 
also aill investigation into cellu­
I<u' functions such as motili ty, 
cytoskeletal structure, endocy­
tosis and cell division _ Under 
the direction of Urban C 
Bcrgbauer, trustee, the founda­
tion ha~ donated more than 
$500,000 tt) thl:! department '~ 
protein synthesizing facility. • 
lot S II f . on C .. I~ 
oseph L. Roti Roti , Ph.D., 
associate professor of ra­
diology. has been awarded 
$200.657 [ron th National 
am:er Institute in the form of 
two research grants to study 
the effe ts of hyperthermia­
the use of heat to shrink 
cancerous tumors - on cell 
~tructure. 
The lir;;t grant wi ll allow 
Roti Roti and co-researchers 
to study the effects of radiat ion 
and hyperthermia on nuclear 
organization and function _ 
In particular, the six-year Mudy 
is aimed at de.ermining 
whether or not heat and x ray­
induced changes inhibit cell 
reproduction . 
The sct·ond grant wi ll 
enable him to study the corre­
lation belwe n heat-inuuced 
change in nuclear protein~ and 
growth dela in anceroll s 
tumors. "Our ovemll goal," he 
says, "i to explain the biologi­
cal mechanism of therapeutic 
methods." 
Roti Roti Wjj~ an a<;soc iate 
professor of radiology at the 
University of Utah School of 
Medicine in Salt Lake City be­
fore being appoi nted to hi ~ pre­
sent po!)ition althe university 
in 1985. He i-; th recipient of a 
number of research grants in 
cell kinetics and structure and 
has contributed nearly 50 
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Clinical trials of a new vaccme agamst Haemophilus influen­
zae type b (Hib) - a bacterium 
responsible for bacterial 
meningitis and a number of 
other life-threatening child­
hood illnesses - show that the 
new vaccine for the first time 
affords protection in infants 
from two to six months of age. 
"This study marks the first 
time an~ vaccine has produced 
antibody levels considered 
capable of protecting infants as 
young as two months," says 
Dan M. Granoff, M.D., profes­
sor of pediatrics and associate 
professor of microbiology and 
immunology. 
"Of the 63 chi Idren we im­
munized, 25 were 8-17 months 
old and 38 were younger than 
six months," Granoff says. "In 
most cases, even a single injec­
tion raised antibody levels 
among infants younger than six 
months higher than those pro­
duced by any other Hib 
vaccine." 
Robert Daum, M.D., head 
of pediatric infectious diseases 
at Tulane University, calls 
Granoff's work "groundbreak­
ing. The exciting thing is that 
this new vaccine looks fantasti­
cally immunogenic, capable of 
protecting young children at 
their peak susceptibility to the 
disease." Daum is a member of 
the American Academy of 
Pediatrics committee on infec­
tious diseases. 
"Most of the infants in our 
study showed further increases 
in antibody after a second in­
jection," Granoff continues. 
"We're encouraged by these 
results because a vaccine that is 
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Dan M. GratwfJ, M.D. 's, research team determined the levels of 
antibody against Hib bacteria in normaL subjects. Their new 
vaccine is effective in children most vulnerable to Hib disease 
those younger than 24 nwnths. 
can confer Hib inununity to 
millions of children who aren't 
protected by the currently 
licensed vaccine, or who'd be 
poorly protected even after two 
doses of the other unlicensed, 
investigational Hib vaccines 
tested to date." 
The vaccine currently used 
against Hib di sease, which was 
licensed in 1985 and is pro­
duced by several companies, 
contains a purified piece of the 
Hib bacteria's outer coating, 
which is composed of linked 
sugars called polysaccharides. 
Thus the currently licensed 
vaccine is known as Hib poly­






I I I I I I I I --L­
20 30 40 50 60 70 80 90 Adults 
AGE IN MONTHS 
' 
In a large National Institutes 
of Health-sponsored clinical 
trial , this Hib PS vaccine pro­
duced significant antibody 
levels in older children but was 
found to be totally ineffective 
in infants less than 18 months 
old, the age group at highest 
risk for Hib disease. 
In 1984, representatives 
from Merck Sharp and Dohme 
asked Granoff's team of sea­
soned investigators - who'd 
tested the Hib PS vaccine and 
who were experienced in evalu­
ating responses to immuniza­
tion - to test a new vaccine: 
an Hib PS protein conjugate. 
In the new vaccine, Hib PS 
is li nked to a protein pu rified 
from a meningococcus bacteria 
which, like Hib, is al so known 
to cause meningitis. T his con­
jugation of PS to protein 
~.. 
greatly enhances antibody re­
sponse within infants. In addi­
tion to choosing the correct 
protein to ac t as a spark plug 
for J-Iib PS, researchers also 
found a unique way to li nk Hib 
PS and protein without dis­
turbing the Hib PS bacteria­
fighting activity 
In spite of promising results, 
which were recently published 
in the prestigious Briti sh 
medical journal Lancel, work 
must st ill be done before the 
new vaccine can be licensed. 
"We have to determine the op­
timal dose and immunization r ­
schedule," says Geoffrey A . 
Weinberg, M.D., a research fel­
low and co-author of the Lancet 
article. "We' re not yet sure of .-I 
the precise level of antibody re­
quired to provid protection , -~ ~ and we have to be w re that the 
antibody produced by thi s vac­
cination will last. " 
Granoff 's team has already 
immunized more than 100 ad­
ditional infants si nce comple­
tion of the Lancet study. In this 
second trial , infants agai n 
produced good anti body levels 
with few side effec ts. 
Once the exact dosc and 
schedule are refined , the next .... 
step is a series of trials in 
which thousands of children 
are vaccinated and monitored 
for several years to make sure 
they remain immune to Hib. 
These trials will also detect any 
safety problems that might 




"We can't yet swear by the ,.~j 
Hib PS-protein conjugate vac­
cine," Weinberg says. "but it 
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~ ' . onald G. Sessions, 
M.D. '62, has be nt~ 
named president of the 
Washington University Med ical 
Center Alumni Association. 
An expert on the surgical treat­
ment of head and neck cancers, 
Sessions is professor of 
otolaryngology and director of 
resident training for the 
otolaryngology department. 
Sessions graduated from the 
School of Medicine in 1962. 
After completing an inte rnship 
and residency in surgery at 
Vanderbilt Hospital in 
Nashville, Tennessee, he 
returned to Washington Uni­
versity for a residency in 
otolaryngology. Following mil­
itary service at the U. . Air 
-.1,. 
Force Hospital in Anchorage, 
Alaska, he was named assis­
tant professor of otolaryngol­
ogy at Washington University 
in 1970. 
Sessions is on staff at 
Barnes, Children's and Jewish 
hospitals. He is a member of a 
number of professional organi­
zations, including fellowship 
in the American College of Sur­
geons, the American Academy 
of O tolaryngology - Head 
and eck Surgery, the Ameri­
can Academy of Facial Plastic 
and Reconstructive Surgery 
and the American Society for 
Head and Neck Surgery. He 
has published numerous jour­
nal articles in his field and is 
the author of a textbook, Atlas 
ofLaryngeal Surgery. Sessions 
has a special interest in well­
being and the doctor-patient 
relationship and is currently 
doing research in this area. _ 
Donald G. Sessums, M.D, '62 
PC"IT\' IlcHlured for 
'ltoadlill;,! (;ood 
11.'a .o( II..bib 
. Mitchell Perry Jr., 
M. D., professor of 
. medicine and director 
of the hypertension division, 
has received the Louis B. 
Russell Jr. Memorial Award 
from the American Heart 
Assoc iation. 
The award recognizes Perry 
for outstanding achievement in 
educating minorities about life­
styles that are healthy for the 
heart. Louis Russell, a black 
Indianapolis teacher, received a 
transplanted heart in 1968 and 
was an energetic volunteer for 
the American Heart Associa­
tion until his death in 1974. 
Perry was cited for a project 
he created to help solve a major 
problem in the St. Louis area: 
identifying young, black males 
with uncontrolled hypertension 
who face potentially fatal med­
ical problems. The program 
Perry developed began in 1982 
and called for door-to-door 
canvassing of minority commu­
nities to locate and treat people 
with high blood pressure. He 
directed the project, which was 
funded by the St. Louis chapter 
of the American Heart Asso­
ciation and was a cooperative 
community effort involving a 
number of educational institu­
tions and health organizations. 
Perry has been director of 
the hypertension division at the 
School of Medicine since 1957 
He also serves as director of the 
hypertension program at the St. 
Louis Veterans Administration 
Hospital, and as physician co­
ordinator for the VA's national 
hypertension program. 
He is currently directing 
the St. Louis section of a 16­
center national study called the 
Systolic Hypertension in the 
Elderly Program (SHEP). The 
study is designed to learn 
whether lowering systolic 
blood pressure with drugs will 
decrease heart attacks and 
strokes. It also investigates 
whether medication can favor­
ably affect memory and mental 
powers in people aged 60 and 
older. 
St. Louis researchers plan to 
enroll at least 300 men and 
women aged 60 and older with 
isolated systol ic hypertension 
by March 1987 More than 200 
volunteers are participating in 
the local study. More informa­
tion about SHEP is available 
through the SHEP office, 
314-367-2547 ­
L(J~all CiH'~ . ' ('W
'. 
' lwi~l tn "Ioi~t~ 
Samuel E. Logan, M.D., Ph. D., assistant profes­sor of plastic and recon­
structive surgery, has received 
a three-year grant of $150,000 
from the Whitaker Foundation 
to continue investigating the 
complex anatomy of the wrist. 
In the future, he hopes to eval­
uate and design improved wrist 
operations and possibly an 
improved wrist prosthesis. 
Logan's research is a collab­
oration among a number of 
investigators in the Division of 
Plastic Surgery and Michael 
Vannier, M.D., associate 
professor of radiology. 
Logan is assistant professor 
of mechanical engineering at 
Washington University School 
of Engineering and Applied 
Science. _ 
5 
" .. w Di n'('(OI" 
or \ hlln II i alUl 
D."n-Iul HlU'.11 
Pl'ogTHIU'" 
he School of Medicine 
b id ~ farewell to Jack 
Siefkas, director of 
medical development programs, 
and welcomes hb replacement. 
Mark W Bates. 
Sicfkas, who served a~ di ­
rector of medical alunUli ami 
development programs ibr four 
years, will be doing develop­
ment work at the niversityof 
Kansas for a Chicago-ba~ed 
consulting fi rm. 
Bates comes to the School of 
Medicine from the OUice of 
University Relations at the Hill­
top Campus. where he served 
as assisttUlt vice chancellor and 
directur of )pedal tkvdupmenl 
programs. Batc~ came to the 
uni versity in 1985 with nearly 
27 years of insti tution(ll ad 
vanccment experience in 
Chicago, having served as 
vice president and exccut ive 
~ecretar} to the board of trust­
ees at Iliinoi ~ Institu te of Tech­
nology. and executive vice 
president of the American 
Fund lor Dental Ilealth. 
A jollmalism gradlJ<lte from 
orthwestem Universi ty, Bates 
ha. also served as vice 
president for institutiona l 
advancement at the allege of 
Sl. Francis in Joliet, and vice 
president for a developmcnt 
consulting firm whose cl ients 
included the Chicago Sym­
phony Orch stra . • 
: . 

Nicholas T. KoucilOlikos, M.D, use~'llll alltotrallsfllsioll system he 




ccycling a patient's 
own blooo during and 
after open-heart ~l1r-
gery C<lIl, in some ca"c". l.!Onl­
plctely eliminate the need for 
donor blood 
In a recent study ot' this 
method conducted by il.! holus 
T. Kouchoukos, M.D.. John M. 
Schoenberg Profes!>or of 
Cardiovascular Surgery. allLl 
Wi lliam G. Marshall Jr.. M.D.. 
a<;s iSlant professor at "urgel·Y. 
32 percent of 115 coronary 
artery bypass graft patients 
necded no donor blood . 
Among those under the age of 
70. 38 percent recei ved no 
donor hlood . 
··This auto-transfUSion sys­
tcm has proven to be sate. 
econom ical and ~imple to usc 
and results in the saving~ of 
substantial amounts of red 
blood cells and platelet),." 
Kouchoukos says. 
The auto-transfusion system 
lflvolves a fairly simple appara­
tus that collects and ti lters 
blood 10. t as che. t drainage 
early after ~urgery That hlood 
i ~ gradually reintroduced III the 
pat ient\; body through all infu­
siun pump during the flr~t IK 
hours after surgl!ry. salvaging 
an average of lInce un i L~ of red 
blood cclb. To date. auto­
tram.ru~ion has not been found 
to be a~so~: iated with any sig­
nificant complications, <;uch m. 
in fection or hkcding requiring 
fe-operation. 
" Because of concerns from 
both potential blood donors 
and potent ial recirient~ con­
cerning AJDs. as well as hepa­
tit is and other disorde~ thaL 
can be transmitted by blood 
transfusions, an auto-transfu­
sion svstem that can minimize 
the usc of donor blood has 
additional relevance." 
Kmlchouko. adds. 
"Whik: the risk of contract­
ing one of lhe-.c dborLler:, is 
extremely low. these anxieties 
have placed pressure on the 
blood supply and an under­
stamlahle reticence among 
some patienb to accept donor 
blnod . We cannol guarantee 
Lhat no donor blond will be 
used. but we know that 
elirr llnatinL! or minimiZing its 
use has p{)~itive dTt:cts both on 
the bl loo supply and on patient 
morale. and docs reduce the 
risk of contr.lcting any of (hc.se 
disea..es .·· 
, , 
uuth who hegin u~ing 
dnIgs before age 15 are 
more likely to develop 
severe drug abuse or depen­
dence than those who postpone 
dnIg use lI nlil a later age, 
according \0 a study by inter­
nationally recognized drug 
abu'ic expert Lt:e N. Robin~. 
Ph .D.. professor of sociology 
in psychiatry. 
According to her study, or 
all the participants who used 
drugs five times or more, 25 
percent of men and In percent 
of women developed a drug 
disorder (abuse or depen­ + 
dence). When usc began before 
the a!!e of 15. however. the 
figur~s more than doubled: 51 
percent of the men and 39 (Jl!r­
cent of lhe women developed ,. 
drug Llisorders. A., hTht Llrug 
use wa... delayed, the risk of 
developing a drug disorder 
decreased. lIle study showed. 
"We don't know yd why 
carly usc of dnIgs is so danger­
ous, but one n:ason may be 
that it makes kids drop ()ut of' 
school." Robins suggests. 
" With no skill~, they have no 
way of re-entering society 
when they give up drugs, as 
many will by their early 20s. 
Thl: problem is how to prevent 
other~ from starting drugs 
without irreparably Llamaging ..... 
the kid, already involved 
with drugs." 
Not only is under 15 the 
mt), t dangemus age for onet 
of drug Ll~e, it also i ~ lIle ea~iesl I· , 
time to intervene. Robins 'iay.... 
"One of the advantage~ of 
working with younger kids i~ 
that it is easier to monitor their 
















leaving school at lunch is more 
acccptabk to a 12- to 13-year­
old than to a 17-year-old. The 
re ·t fictions are more readily 
accepted by younger kid~ . 
8 L:ause the law says children 
have to stay in school until they 
are 16, it is much safer to con­
front younger kids; older kids 
may just dr)p out rather than 
accept the :>trict new rule~. " 
Her stUlly, "Age of Onset of 
Drug Use a~ a Factor in Drug 
and Other Di ~orders," co­
authored with Thomas R. 
Przybeck , Ph.D., a statisliL:al 
data analysl, was pn.:pared fo r 
the auonal In litute of Drug 
Abuse. h was published by 
the Department of Health an j 
Human Servi es in "Etiology 
ot Drug Abuse: Il1lplicntions 
il1f Prevcntion." 
Robins' ~ludy involved per­
sonal intcrview~ with partici ­
pant, aged IR 10 35 in ew 
Haven , onn.: Baltimore: and 
51. Lou i~ . Respondents were 
interviewed first between 1979 
and 1981 and reinterviewed 
a year later. 
The study show,> that sex , 
race and education arc only 
weakly related to drug disor­
ders, wi th slightly higher ratc~ 
{or males, whites and i.nner-city 
residents. Beginning drug use 
before age 15 predicted an in­
creased risk of drug di. order .. 
particularly of a severe type. 
Early onset ot use wa!'> also a5­
sociatcu with more alcoholism 
and antiSOCial personality in 
later life. 
The researchers looked for 
factors that coulll predict drug 
use. "Early ochavior prohkms 
are very good predictor:, of 
substance abu e." Robins 
says. "although many drug 
abusers are apparently norma l 
children." 
The leading predictors of 
on. et of drug use are: early 
drunkcnnes~, school discipline 
problems. depre~~i()n. stealing, 
vandalism <Inu truam:y. the 
'itudy shows. Broken home~ 
al. 0 predicted drug abuse, but 
were much less important that 
the child ' own beha lor 
Robins has a new grant from 
the Na! ional lnstitute of Drug 
Abuse and the ationa! In 'ti­
lute ( f MCI1tal JleaIth to study 
...... hether drug abuse by normal 
youth differs in character and 
consequence~ from abu ~c by 
those with a 1roubled beh:wior 
history. " Becau~e only 50 
perct:n l of the dnlg lI~ers hat.! 
earlier Ix!havjor prohlems, we 
want to know what the path­
ways are to drugs for kids who 
do not bav behavior prob­
lems." Robins ~ay~ . ­
Can('el" SU('if' f, 
. 
Elt'('(:-. L(WI. 
Virgil Loeb Jr. M.D '44, professor of cllmcal medic ine. has been 
elected President of thc Amcri­
can Cancer Society. 
Loeb succ~eus Chnrles A . 
LeMail>tre, M.D. , of Houston, 
who served tiS the Society's 
Pre~ide l1 t for the ll}gS-86 tCnll. 
During his tenure as presi­
dent. Loeb plans to stress a 
message of hope concerning 
cancer. "Half of all cancer pa­
tienb today are being cured, " 
he ~ay~. "We have made 
r~mar able progres\ uuring re­
'en! decades in detecting and 
treating cancer and in the 
under~tanding of the biology 
of I:ancer <I, wel l. Evidence 
~e ms to int.! iL:ate thal we have 
even greater prospect to pre­
vent cancer by maki ng careful 
choice~ in our lifestyles. For 
example, by choosing wisely 
what we cat and choosing not 
tl) smoke, we R'li ul'c our risk 
of cancer considerably. 
"We in the American Cancer 
SOCIety cal l such choices 'lhk­
ing Control,' and we have de­
signed a program by that name 
to guide pel)ple in making 
value wi5c decisions relating to 
cancer rish.. Urging Americans 
to take control ol their lives by 
making educated choices in 
cancer detection. trealment and 
prevention will be (lur ml:S 'age 
Juring the year to come." 
After receiving his M.D. . 
Loeb 'on pleted internships, a 
kllow hip and residency at 
hospitals in Missollfi and Con­
necticut and a traineeship ith 
the National Canc r Institute, 
returning to the university in 
1950 a-; a Damon Runyon Re­
,earch Fellow in Hematology 
Currently :l member of 
the Board of cientific Coun­
selors of the Division of ancer 
Prev ntion and Control of the 
ational Cancer Insti tute and 
of the Institute of Medicine of 
lhe National Academy of 
Sciences, Loeb has also served 
on numerous commiltees of 
the American ancer Society 
and other organilati( ns. He 
joined the National Board of 
Directors of the Socicty in 
1979, and is a former president 
of both the ACS Missouri Di­
vision Board and the SI. Loui s 
nit Board. 
His professional member­
sh ips include the American 
Board of Internal Medicine. 
the American College of Physi­
cians, the American Associa­
lion tor Cancer Research and 
the American Societ of Clini­
cal Oncology. 
A nati ve of St. Louis, Dr. 
Loeb is married to the fom1er 
Lenore Harlow. They have two 
daughters and two sons. ­
Virgil Loeb Jr., M.D., talks with his pa/im/ and cousin, Fay 








t happens in Alzheimer 's disease, 
Huntington's chorea , epilepsy and other 
well known neurobiological disorders. It 
happens in cerebral palsy, cardiac arres t, 
stroke, hypoglycemia and other cases where 
the brain's supply of precious oxygen or 
glucose is interrupted. It happens in head 
injuries from football games, stai rway 
tumbles and auto accidents. 
Nerve cells in the brain die and are not 
replenished - the brain is damaged. 
But two decades of research by John W 
Olney, professor of psychiatry and neuro­
pathology, have brought us closer to under­
standing the mysterious causes for such 
brain damage, and accumulating evidence 
suggests that novel drugs may soon be in 
the kits of physicians, even paramedics, to 
prevent nerve cells from dying in at least 
some of these conditions. 
This is not a story of a medical break­
through. There were no flashes of light, no 
cries of "Eureka l " It was more ofa medical 
"wearthrough," a tedious trek towards a 
new understanding of neuropathological 
processes that began in 1968. 
Prior to that time, a common amino acid 
called glutamate (Glu), which is found in 
high concentration in brain, had been 
shown to have an excitatory effect on cen­
tral neurons. Paradox ica lly, this same 
substance also was found to cause the 
degeneration of nerve cells in the immature 
retina of baby mice, when injected under 
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As a resident at Washington University 
School of Medicine in the late 1960s, Olney 
confirmed Glu 's damaging effects on imma­
ture mouse retina using both light and 
electron microscopy. Then he found that 
treatment of mice with Glu in infancy 
caused them to have a grossly abnormal 
body constitution as they grew to adulthood 
- they became obese, short and often 
sterile, By 1969 he had traced the cause of 
these developmental abnormalities to a toxic 
action of Glu on nerve cells in the hypo­
thalamus, a brain region that exerts regula­
tory control over growth and development. 
At this point he knew that he was in hot 
pursuit of something very intriguing: [f Glu 
occurs naturally in high concentrations 
throughout the central nervous sys tem , 
how can it also be a toxin that can kill 
nerve cells? 
In the ensuing decade, Glu became 
recognized as an exceedingly important 
substance in the brain, Not only is it a major 
building block in the formation of important 
brain peptides and proteins, but it also is 
a neurotransmitter that excites ce ntral 
neurons, thereby mediating information 
transfer from one cell to another. Indeed, it 
is currently believed to be the neurotrans­
mitter released at the majority of excitatory 
synapses in the central nervous system. 
Recognition of Glu as mediator of vitally 
important functions in brain made the 
enigma confronting Olney all the more 
challenging. The paradox: A substance 
integral to the brain's information proces­
sing functions has the potential of killing 
brain cells. 
Major progress in unraveling the mystery 
was achieved by studying a large number of 
Glu analogs. Prominent Australian elec­
trophysiologists, David Curtis and J.c. 
Watkins, found that some Glu analog ' re­
produce the neuroexcitatory effects of G lu, 
and some do not. In 1970, Olney demon­
strated that the same Glu analogs that repro­
duce the excitatory effects of Glu also 
reproduce its neurotoxic effects. This basic 
observation has been confirmed repeatedly. 
Thus, the excitatory mechanism by which 
Glu passes messages from one cell to 
another is believed to be the same mecha­
nism by which it kills nerve cells. "Glu 
might be viewed as a Jekyll and Hyde 
molecule," Olney says. "When present in­
side the nerve cell in normal concentrations, 
it is a benign substance that plays exceed­
ingly important roles in brain physiology ; 
if released from the nerve cell and not 
immediately taken back up, it interacts per­
sistently with excitatory receptors on the 
external surface of the nerve cell and , in 
essence, excites the cell to death. " To 
describe this unique duality, Olney coined 
the term "excitotoxin ," a term which is now 
in common use among neuroscientists. 
The most immediate impact of this dis­
covery was its research applications. Before 






brain function used a method that seems 
quite crude by today's standards. A wire 
was inserted into the brain of an anes­
thetized animal, and a given area of the 
brain was destroyed when electric current 
was passed through the wire. Any loss of 
function or change in behavior was tenta­
tively attributed to the cells destroyed. 
"The trouble with this method," Olney 
says, "is that it destroys everything in the 
area, including fibrous tracts that inter­
connect other brain regions. Sure, you can 
observe loss of function, but you cannot 
confidently attribute it to loss of the 
I targeted cells; it might reflect the fact that 
'1 fibers interconnecting other cells have been 
severed." Excitotoxins act at excitatory 
receptors on the surface of the target nerve 
cell, but fibers of passage are not damaged 
because they do not have such receptors. 
Olney 's research has resulted in the identifi­
cation of numerous excitotoxic analogs of 
Glu that are much more powerful than Glu 
and interact selectively with specific Glu 
receptor SUbtypes. "By carefully choosing 
the Glu analog that matches the receptors 
on the cell types targeted, researchers can 
destroy nerve cells with greater selectivity," 
says Madelon T. Price, Ph.D., research 
assistant professor of neurobiology in 
psychiatry, who joined Olney's research 
team in 1974. 
The excitotoxin approach provides more 
reliable results than could be obtained with 
the old electric current method . "It 's a sort 
of chemo-surgery," says Olney, "that allows 
one to draw more specific conclusions 
with regard to which nerve cells are respon­
sible for which functions." 
The most dramatic impact of excitotoxin 
research is its potential clinical applications. 
In the early 1970s, Olney expressed the view 
that, given Glu's ubiquity in brain and strik­
ing neurotoxic potential , it would be sur­
prising if Glu irregularity wasn't implicated 
by neurodegenerative diseases. "In fact, 
over the past five years researchers from all 
over the world have been reporting new evi­
dence potentially linking the excitotoxic 
action of Glu to brain damage associated 
with epilepsy, stroke, cerebral palsy, Hun­
tington's chorea, Alzheimer'S disease and 
several other less well known neurological 
conditions," Olney says. "On the basis of 
L 10 
very recent evidence, it has even been pro­
posed that a defect in the Glu transmitter 
system might playa role in schizophrenia." 
"We suspected early on that clinical ap­
plications would be found ," Price says. "But 
the number of potential clinical applications 
turning up is rather bewildering." 
Between nerve impulses the Glu is stored 
safely inside cells. During the transmission 
Some Glu afUllogs cause more damage to 
nerve cells than others. A serres ofthree 
micrographs showsfrom top to bottom: un­
damaged retifUl, partwl damage to retifUl 
from one Glu afIillog and extensive retinal 
damage from yet another Glu afUllog. 
of a nerve signal, it is released from the cell - .. 
in tiny amounts for a fractiG ~ of a second, 
then immediately taken back up so the ex­
..
citatory receptors will not be excessively ' 
stimulated. The mechanisms responsible for 
gathering up Glu after it has performed its 
message-carrying function and returning it 
to the cell's interior are normally very 
efficient. However, under abnormal circum­
stances - for example, when the brain's 
supply of blood, oxygen or sugar is deficient 
- these mechanisms fail , and Glu begins 
to accumulate outside the cell. Breakdown 
of the delicate mechanisms that hold Glu in 
check can lead to a rush of excitotoxin - a 
glutamate tsunami - which floods numer­
ous receptors with brain poison. 
The role of Glu in the neuropathology of 
head trauma is not well understood, but 
there is basis for suspecting that physical 
trauma, such as an auto accident or even 
neurosurgical procedures, can cause a re­
lease of Glu from its storage compartments 
inside the cell. Glu has several "metabolic" 
functions in add ition to its transmitter 
function. A common amino acid, it is 
ubiquitous as a component of proteins. 
Every brain cell contains much larger 
amounts of Glu than are necessary for 
transmitter purposes. It is thought that brain 
trauma results ;n the release of Glu from 
metabolic as well as transmitter storage 
compartments and, because receptors do 
not distinguish between metabolic and 
transmitter Glu, they are over-stimulated 
by excesses of either. 
-
"If we could find a way to block Glu \ - ­
receptors," Price says, "we might be able to 
,­
protect those cells from being killed and 
prevent a lot of brain damage. " 
According to Olney, it is not unreali stic 
to believe that Glu receptor antagonists will 
one day be used successfully to prevent 
brain damage from stroke. 
Steven Rothman, M.D., assistant profes­
sor of pediatrics and neurology at Washing­
ton University, has contributed valuable 
evidence on this point. When nerve cells 
grown in culture are deprived of oxygen , 
they rapidly die; but Dr. Rothman has 
shown that they can be protected from 
death by adding a Glu receptor antagonist 
to the culture medium. Swedish inves­
tigators have shown that when the blood 
- - - - - · _ . _ . 



























sing a Glu analog to selectively 
.Jdestroy nerve cell groups known to 
be damaged in Alzheimer's disease, 
Olney and his colleagues have created an 
animal model of the disease's effects 
on memory. 
In the behavioral lab at Shriner's 
Hospital, David Wozniak, Ph.D., research 
associate in psychiatry, tests the memory 
capacities of rats using a radial arm maze. 
When he places a rat in the center of 
the maze, it is free to run down any of 
eight alleys, each leading to a chocolate 
chip. Once the rat has selected an alley, 
Wozniak uses string pulleys to close 
the trap doors to the other seven alleys; 
the remaining trap door is closed after 
the rat has returned to the center. After 
five seconds, the trap doors are re-opened 
and the process begins anew. 
As it h .. s already eaten the chocolate 
chips in the traveled alleys, the rat must 
enter a new alley to obtain its "chocolate 
fix." Wozniak observes how much time 
it takes for normal and brain-altered 
supply is cut off to certain portions of an 
animal's brain, there is an outpouring of 
Glu from brain cells. In the absence of oxy­
gen, the mechanism responsible for taking 
Glu back into the cell stops working. Thus, 
Glu remains in contact with receptors for 
a prolonged period, and cells are destroyed. 
It has been shown in this type of animal 
model that cell death can be prevented by 
injecting a Glu receptor antagonist directly 
into vulnerable brain regions. 
A major problem, until very recently, has 
been the fact that none of the known Glu 
receptor antagonists passes readily across 
blood brain barriers. However, Olney's re­
search team recently identified agents that 
effectively block Glu neurotoxicity and can 
pass from the blood into brain. "We have 
found that such agents prevent brain dam­
age associated with prolonged seizures," 
says Olney, "and 1 am optimistic that they 
will prove effective in preventing other 
forms of brain damage." 
A special problem in preventing brain 
damage associated with stroke is that you 
can't get the receptor blocker to the part 
of the brain undergoing damage because 
the blood vessel feeding that brain region 
is plugged with a clot. With the use of 
new drugs that can quickly dissolve such 
I 
rats to remember and make eight "cor­
rect" alley choices out of nine. 
Preliminary results have shown that 
it takes rats with analog-induced 
Alzheimer-like lesions considerably 
clots, Olney believes that one of the first 
clinical applications of excitotoxin research 
may be in the management of stroke. "I can 
easily envision treating stroke patients 
with a combination of a blood clot dissolver 
and a Glu blocker," he says, "a sort of 
brain-saving cocktail." 
Olney 'S team is also interested in apply­
ing Glu blocking agents to prevent brain 
damage associated with respiratory failure 
in newborns. Emergency measures usually 
restore spontaneous breathing, but lack of 
oxygen during the period of respiratory fail­
ure, even if relatively brief, can give rise 
to cerebral palsy. The prime suspect: cell 
damage caused by an accumulation of Glu 
at excitatory receptors. "If a Glu blocker 
were used at the first sign of trouble," Price 
says, "it may be possible to prevent that 
brain damage." 
One of the most potent GJu blockers 
Olney has identified is phencyclidine (PCP), 
a psychedelic drug otherwise known as 
angel dust. Olney's team has shown that this 
ordinarily devastating drug and related 
agents powerfully protect nerve cells 
against the toxic action of Glu and also pre­
vent brain damage of the type caused by 
seizures. Present evidence suggests that 
longer to achieve this criterion than it 
does normal rats, indicating the powerful 
and debilitating effects the lesions have 
on memory. • 
these agents also protect nerve cells from 
dying when the blood supply to the brain 
has been cut off. Thus, angel dust or related 
drugs may assume a new image one day as 
protectors of human health. 
And, as angel dust is not only a powerful 
blocker of Glu receptors but produces, in 
normal individuals, two common manifes­
tations of schizophrenia - hallucinations 
and delusions - Olney and his colleagues 
are becoming fascinated with the possibility 
that dysfunction of the Glu transmitter 
system might playa role in schizophrenia. 
The list goes on . There is speculation 
implicating an excitotoxic mechanism in 
Huntington's chorea and Alzheimer'S 
disease, both of which involve the death of 
specific nerve cells. Olney considers this 
relatively unlikely but he says, "Ten years 
ago, I could not have predicted that we 
would find an excitotoxin link to the brain 
damage associated with epilepsy, stroke, 
perinatal asphyxia or cardiac arrest." Re­
searchers around the world are carefully 
studying the potential implications of recent 
findings .; I this new field of excitotoxicology 
- a field that can truly be considered 
Olney's brainchild , born and raised in his 
psychiatry laboratories at Washington 
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Like many short children, Justin was 
average size at birth, weighing 7 pounds 8 
ounces. Though he was a small toddle" that 
seemed quite normal because hi s mother is 
5 feet 4 inches, and his father 5 feet 7 inches. 
Only when he reached the age of 4 did 
anyone notice a problem. Just before Justin 
entered kindergarten, the specialist who 
measured him for orthopedic shoes dis­
covered that Justin's feet hadn't grown at 
all in the last year and a hal f. 
About 2.5 percent of all children fall 
below the normal height range for their age 
- that's over 1.75 million kids in the United 
States alone. Those with abnormal propor­
tions tend to have chromosomal defects or 
bone disorders, whereas children who 
are simply short may have kidney disease, 
gastrointestinal disorders or endocrine 
problems. 
Short children like Justin, who have 
endocrine disorders, are the target of a new 
study at the School of Medicine that began 
last spring and will continue until 1990. 
Headed by Dennis Bier, M.D., professor of 
pediatrics and co-director of the Division of 
Endocrinology and Metabolism at Chil­
dren's Hospital, the study aims to identify 
new causes of growth failure . It will also 
see which types of patients can respond 
to growth hormone, a protein that triggers 
growth. 
Growth hormone has been used to treat 
short children for the past 25 years. The 
School of Medicine was one of the first 
institutions to use this therapy, but until re­
cently the hormone had to be purified from 
the pea-si7.:d pituitary glands of cadavers 
and was therefore in very short supply. 
When Justin Leib sought treatment else­
where in 1979, he was refused the hormone 
because he did not meet the strict criteria 
for its distribution. But on Washington's 
Birthday in 1983, he obtained treatment at 
Washington University by taking part in a 
clinical trial of human growth hormone 
made through recombinant DNA technology. 
The recombinant hormone was approved 
by the FDA in October 1985, after the natu­
ral hormone was banned for further clinical 
use because in rare instances it seemed to 
be linked to a dementing neurological dis­
ease called Jakob-Creutzfeldt syndrome. 
, T 
ehave a lot of 
hypotheses, but we don't know 
whether individuals will 
respond unless we put our 
ideas into practice." 
This normally rare condition is caused by 
a virus that infects the brain, so it could 
be transmitted by contaminated human 
pituitary tissue extracts. 
When Justin started his growth hormone 
injections at the age of 81/2, he was only 
431/2 inches taJl - the height of an average 
6-year-old. His response was immediate, 
and he began to grow an astonishing inch 
every two months as he started to catch up 
in height. "There was a time when he grew 
out of a pair of tennis shoes every six 
weeks," his mother recalls happily. "And 
last year, after we had a major fire at our 
house, we were given lots of gifts from 
friend s. One was an expensive pair of jeans 
for Justin , which I saved for a trip to Disney 
World. But when we got there three weeks 
later, he couldn't get into them, and I had to 
go buy him another pair." 
The boy who once heard his mother's 
friend describe him as " the little guy who's 
no bigger than a bar of soap" is now 58 
inches ta1l - just over the average height 
for his 111/2 years. When his family recently 
moved to a new town , and his mother Kathy 
had to explain why he was having shots, 
her new friends found it hard to believe that 
he had ever had a growth problem. 
At present, the FDA sanctions growth 
hormone therapy only for children like 
Justin, with growth hormone deficiency. 
"But most of us feel that there are many 
other children who will respond to treat­
ment, though this has not been clearly es­
tablished," says William Daughaday, M.D., 
the Irene E. and Michael M. Karl Professor 
in Metabolism. "For example, there may be 
patients who are partially growth hormone 
deficient who may respond to higher doses 
than we were able to obtain in the past. " 
Widening the scope of growth hormone 
therapy isn't the only aim of the study; how­
ever, another goal is to identify defects other 
than growth hormone shortage that lead to 
short stature. "Five or six years ago, we re­
alized that methods for evaluating growth 
deficiencies were not adequate," Bier says. 
"For example, many children that were 
diagnosed as growth-hormone deficient 
were not really lacking in the hormone. In­
stead, they were unable to release the hor­
mone from the pituitary." 
Only 10 percent of short children who 
come to the endocrine clinic because of 
their size have problems that can be rou­
tinely diagnosed. "The other 90 percent are 
the ones we are particularly interested in, 
regarding the mechanism of growth impair­
ment ," Daughaday says. "One of our major 
interests is in recognizing individuals who 
put out abnormal growth hormone or ab­
normal somatomedin, a growth-promoting 
protein that is made in the body in response 
to growth hormone." 
The study will include about 50 of the 
300 to 400 short children who are referred 
to Children's Hospital each year from 
southern Illinois and eastern Missouri. Dur­
ing a child 's first visit, a team of pediatric 
endocrinologists consisting of Bier, Sherida 
Tollefsen, M.D., assistant professor of pedi­
atrics, and David Dempsher, M.D., fellow 
in pediatric endocrinology, will take a medi­
cal history to screen out children who are 
not abnormally short, or whose growth 
deficiency is due to causes other than an 
endocrine disorder. 
After screening, children who qualify for 
the study spend three days in Children's 
Hospital, where their ability to secrete 
growth hormone is measured with routine 
clinical tests. They also donate blood sam­
ples and a pinhead-sized patch of skin for 
new growth tests, which have been devel­
oped at Washington University. Over the 
next several weeks or months these samples 
are studied, and the children visit the hospi­
tal regularly to be accurately measured. 
When the results of the tests are avail­
.~ ., 
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James Gavin Ill, M.D., uses radioimmurwassay techniques to detennine iruiividuoJ 
paJients' abilities to secrete growth IUJrlrwtle. 
medin . This intermediary protein is released 
from these cells and binds to somatomedin 
receptors on other cells targeted for growth. 
The binding of somatomedin to these cells 
stimulates them to produce proteins and 
other substances essential for growth. 
This dual-control system, involving both 
growth hormone and somatomedin, seems 
to have many advantages over a system 
involving growth hormone alone, but it also 
provides more scope for error. Thus short 
stature could theoretically be due not only 
to errors in the production or secretion of 
growth hormone, but also to the synthesis 
of a biologically inactive growth honnone 
that can't bind to growth hormone recep­
tors, Deficiencies or defects in those recep­
tors or in somatomedin could also stunt 
growth, as could too few or defective 
somatomedin receptors, 
These hypotheses evolved from studies 
with animals and cultured human cell lines, 
The Washington University study will see 
how they hold up during clinical testjng, 
when defects identified in children by 
laboratory tests will be correlated with re­
sponse - or lack of response - to therapy 
For example, a child with defective 
somatomedin shouldn't respond to growth 
hormone if control of growth has been 
interpreted correctly 
"We have a lot of hypotheses," Daughaday 
says, "but we don't know whether individu­
als will respond unless we put our tests into 
practice. We need to know if our criteria 
for predicting a growth defect are accurate 
enough, " 
The unique aspect of this study is that it 
brings together five principal investigators 
whose combined research covers every link 
in the chain of events between growth 
hormone secretion from the pituitary and 
protein synthesis in tissues. 
James Gavin III, MD., associate pro­
fessor of medicine, focuses on the events 
between growth honnone secretion and 
somatomec:'" synthesis, He measures the 
amount of growth hormone a child can 
secrete by adding a sample of the child's 
serum to radioactive growth hormone com­
bined with an antibody Since each antibody 
molecule can combine with only one 
growth honnone molecule, some of the 





able, and growth rates are established, chil­
dren come back to the hospital for another 
seven days. This time, rate of protein 
synthesis and breakdown is measured 
before and after a couple of days of growth 
hormone treatment. Since protein accretion 
is an essential component for the deposition 
of new tissues, these tests assess children's 
current capacity for growth. 
Before leaving the hospital this second 
time, children begin thrice-weekly injec­
tions of growth hormone, which continue 
for six months - long enough to see even 
belated responses. If growth-rate increases 
by at least half an inch during this period, 
the child stays in the program and receives a 
further six months' supply of the honnone, 
Treating a 10- to l5-year-old child with 
growth hormone for one year costs $10,000 
to $20,000, and that money comes from the 
$2-million grant awarded for the study by 
the National Institute of Child Health and 
Human Development. 
Awareness that short stature can have 
many different causes came after scientists 
began to unravel the complex cascade of 
events that controls growth. When Daugha­
day came to the School of Medicine in the 
1940s, it was thought that growth hormone 
acted directly on tissues to promote the syn­
thesis of new materials, such as cartilage, 
that build the human body So Daughaday 
tried to assay the hormone by determining 
in vitro its effect on the uptake of sulfate 
ions into cartilage - a measure of growth, 
fnstead, he discovered that growth hormone 
has absolutely no effect on cartilage forma­
tion outside the human body 
By 1957, Daughaday discovered the 
reason for this anomaly He found that 
serum from normal rats could stimulate sul­
fate intake, but the serum from rats whose 
pituitaries had been removed could not. 
This led him to the conclusion that serum 
normally contains a growth-promoting sub­
stance he called sulfation factor that is 
induced by growth hormone, This and other 
related proteins are now known as somato­
medins becase they act as mediators be­
tween growth hormone and growing tissues. 
The current hypothesis is that growth 
hormone does not directly stimulate growth, 
but rather acts through the intermediary 
protein somatomedin, which in turn triggers 
cells to increase their synthesis of proteins 
and other substances essential for growth. 
When growth hormone that has been re­
leased into the bloodstream by the pituitary 
reaches certain cells, it plugs into growth 
hormone receptors on their outer mem­




radiolabeled molecules are displaced if 
there is growth hormone in the serum. The 
concentration of the latter can be calculated 
from the amount of radioactivity that re­
mains bound. The principle is similar to a 
game of musical chairs. If five people are 
playing the game with five chairs, each will 
be able to sit down. But if an extra 20 peo­
ple suddenly gatecrash the party, the chance 
of one of the original players getting a chair 
falls to one in five. One could calculate the 
number of gatecrashers from the number of 
original guests that manage to sit down. 
Although this standard radioimmunoas­
say measures the quantity of growth hor­
mone, it reveals nothing about its biological 
activity because the part of the growth hor­
mone molecule that binds to an antibody is 
different from the part that binds to the 
growth hormone receptor. Yet Gavin has 
learned how to use the same principle to 
assay biological activity, using different 
"players" and different "chairs" with a cul­
tured human ceJl line as a source of growth 
hormone that can compete with radioactive 
growth hormone already bound to the 
ceJl surface. If the growth hormone in the 
serum cannol bind to the receptors, Gavin 
deduces that it has an abnormal structure. 
To assay the receptor itself, Gavin hopes 
to compare the binding of radioactive 
growth hormone to fibroblasts from a ceJl 
bank with tha. to fibroblasts grown from 
skin sample~ of the short children in the 
study. So far, he has perfected the technique 
for animal celis, and within the next few 
months he hopes to determine the optimal 
conditions for measuring human growth 
hormone receptors. 
The next link in the chain is somatomedin 
synthesis, for this protein is the net result of 
the binding of growth hormone to its recep­
tor. After incubating a child's fibroblasts 
with growth hormone, Gavin measures 
the quantity and activity of the resulting 
somatomedin with a radioimmunoassay and 
a biological assay. 
The Washington University team is also 
studying somatomedin synthesis at its most 
hen Justin started his 
growth honnone injections at 
the age of 8V2, he was only 
43V2 inches tall- the height 
of an average 6-year-old. 
basic level - by looking at the gene that 
codes for the protein. Peter Rotwein, M.D., 
assistant professor of medicine, finished 
sequencing the normal somatomedin gene 
last year. Now he will look at the gene in 
children with seemingly abnormal somato­
medin, obtaining the necessary DNA from 
their white blood cells. "The assay of 
somatomedin per se is step one - kind of a 
best guess that this one might be abnor­
mal," he says. "So we are going to take it 
from there and try to confirm that the pro­
tein is coded for by an abnormal gene. Then 
we'll try to show that the abnormal gene is 
the problem in that particular individual's 
failure to grow." 
Rotwein will also alter the gene in cul­
tured cells and look at the effect on somato­
medin production and activity. He hopes to 
study the regulation of somatomedin syn­
thesis as well, asking how the binding of 
growth hormone to its receptor switches on 
somatomedin production. 
The final link in the chain - the soma­
tomedin receptor - is assayed in animal 
cells by Gavin in much the same way as the 
growth hormone receptor, but with radio­
labeled somatomedin in place of growth 
hormone. Using an alternative approach in 
human cells, Daughaday measures the up­
take of radioactive amino acid analogs into 
fibroblasts that he stimulates with commer­
cial somatomedin. Since amino acid uptake 
is one of several events that somatomedin 
binding switches on , its rate reflects the 
number of receptors on the cell surface 
and important post-receptor mechanisms 
related to cell growth. 
Tollefsen studies the structure and syn­
thesis of the somatomedin receptor, trying 
to develop methods that eventually will 
pinpoint precise defects She just achieved 
the first purification of the receptor, which 
consists of four polypeptide subunits - two 
alpha and two beta - plus an undetermined 
number of side chains built of sugars. 
ToLlefsen's current goal is to study the bio­
synthesis of the receptor in cultured fibro­
blasts, looking at the complex processing of 
its precursors. Once she has uncovered the 
normal sequence of events, she wi II look for 
abnormalities in children with short stature. 
The study of protein synthesis - the 
business end of the growth process - is the 
province of Bier and Dempsher, and is a 
natural outcome of Bier's 13-year interest ... . 
in the effects of hormones, nutrition and 
disease on human metabolism. As no single 
test can tell if a child's protein metabolism 
is normal, the researchers do several assays. 
On the one hand, they look at the incorpo­
ration of amino acids from food into pro­
teins in the bloodstream. On the other hand, 
they measure the wastage of these amino 
acids as their atoms are excreted in carbon 
dioxide in breath and urea in urine. The 
radioactive labels that are used in the labo­
..
ratory tests would be harmful to children, 
so they label the amino acids with harmless 
stable isotopes that can be detected by their 
slightly different mass. 
By bringing together this wide range of 
.. .
expertise in clinical medicine and basic 
biology, the researchers aim to diagnose any 
defect in the growth-controlling sequence 
Such a study is essential to further progress, 
for physicians must be able to detect the 
cause of a growth defiCiency before they 
can plan rational therapy. The researchers 
are hopeful their labors will open the way 
to new treatments, such as injections with 
recombinant somatomedin for children with 
. . 
defective growth hormone receptors or 

somatomedin genes. Then, like Justin Leib, - , 












"1- - -------­f this were any other virus, this would be the perfect 
vaccine. It replicates, but doesn't kill. It's an attenuated virus just 
like everyone gets vaccinated with for polio." 
- l ~ 
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By sLicing into the DNA ofthe Like a night watchman on his appointed produced, the ungrateful AIDS virus kills rounds, an ever-vigilant helper T its host cell. By killing these critical lym­... '" .~ IfTLV-1I1 virus, Lee Ratner has cell patrols a vessel of the lower phocytes, the AIDS virus short-circuits the 
. I 
genital tract. 	 entire immune system. Without enough created two mutants that do not This circulating sentinel detects a foreign helper T cells to signal the attack, the other 
I I <1 kill hwnan immune cells. but antigen in a nearby capillary bed , determin­ soldiers of the immune system - phago­
ing the invader to be a white blood cell of cytes, killer cells and B cells - are never
may serve as weapons against similar cell type. But as the two T cells called into action, leaving the body wide 
meet, the AIDS virus that was hiding in the open to a constant assault of secondarythe originalform. 
invading cell slips through the cell mem­ infections that include cancer, herpes, in­
branes into the defending cell before that flammations of the lung and brain, fungal 
cell can sound the alann. 	 infections and prolonged diarrhea. 
Once inside the inactive helper T cell, the The human immune system is no match 
subversive AlCS ' irus decodes genetic in­ for the rapidly spreading AIDS virus, as 
formation from it~ RNA core into a DNA evidenced by the fact that half of the mOre 
form that is recognized by the T cell as its than 23,000 Americans who have been 
own and inserted into its chromosomes. diagnosed with AIDS are already dead. But 
There it may Iie dormant for weeks, while the AIDS virus easily defeats the 
months, even years until some other infec­ body's first line of defense (the immune sys­
tion triggers the invaded cell to divide. The tem), this virus has yet to receive the brunt 
viral DNA then reprograms a key com­ of humanity 's surest defense - the mind. 
ponent of the T cell's genetic machinery, so Taking the lead in the mind 's war on the 
that the cell churns out copies of the virus microbe is Lee Ratner, M.D., Ph.D., assis­
1- .. _ ,. 	 faster than it can manufacture its own tant professor of medicine. Collaborating 
cell parts. with Robert C. Gallo, M.D. , from the Na­
... One by one, these viral clones bud from tional Cancer Institute and six other re-
the cell to infect neighboring T cells. And 
after enough copies of the virus have been 
17 
new tool for learning exactly how the AIDS 
"T---------------------------------------­he problem with this class of viruses is that they get 
converted into DNA forms, which go into your chromosomes and ' . 
stay there forever." 
Lee Ratner, M.D., Ph.D. 
searchers, Ratner has successfully cloned 
two mutants of the AIDS VlIuS that may 
eventually be used to beat the original form 
at its own game. 
The genetically aJtered viruses behave in 
exactly the same way as the original AIDS 
virus, except that they do not kill T cells. 
Ratner and his colleagues, who recently 
reported their unprecedented results in an 
August 8 issue of Science, created disarmed 
variants of the AIDS virus by slicing into 
its genes. 
Ratner and his fellow investigators 
opened up circular strands of the virus' 
DNA with a bacteriaJ enzyme that cuts 
through the DNA at only one point on the 
circle. Then they added a second enzyme 
that chews inwards from both ends of the 
DNA, as if it were removing beads from the 
ends of an unclapsed necklace. fn this way, 
they created holes of varying size along the 
DNA strand. After ligating or "reclapsing" 
the ends, the investigators isolated six 
genetic variants which, when added to cul­
tured T cells, produced six correspondingly 
mutated viruses. 
The two non-lethal mutants were created 
more or less by accident, according to 
Ratner. They were fonned when the enzyme 
chewed past the suspected killing gene into 
the next gene, which really does control cell 
killing. The four mutants that contained 
alterations only in the originally suspected 
killing gene retained their ability to kill, 
ruling out that gene as the killing gene. 
Because non-lethal mutants of the AIDS 
virus replicate just like the killing form, 
they may eventually be used to treat AIDS 
patients in the hope that the non-lethal 
forms might outcompete the killing variety 
for helper T cells. Studies are already under­
way to determine whether or not these 
mutants can outcompete the killing virus 
in cultured T cells. "If this were any other 
virus, this would be the perfect vaccine," 
Ratner says. "It replicates, but doesn't kill. 
It's an attenuated virus just like everyone 
gets vaccinated with for polio." 
Although mutants of the virus may be 
used to help people who already have 
AIDS, they wi II probably never be used as 
a vaccine for non-infected patients. "The 
problem with this class of viruses is that 
they get converted into DNA forms, which 
go into your chromosomes and stay there 
forever," Ratner says. A live retrovirus will 
probably never be of any use as a vaccine, 
because it could damage normal genes. 
"Whether it actually would or not, we don't 
know," Ratner says. "But it's too dangerous 
to take a chance." 
Even more important than any clinical 
role they may play, Ratner's mutants have 
provided AIDS researchers with a powerful 
virus kills the T cell. 
"What we have is a mutant 
virus and a wild type 
virus -- both of which 
grow well - and yet 
one kills, and one 
doesn't. Now 
we'll be able to 
separate out the 
effects of 
Dr. Ratner's AIDS 
virus mutants invade 
T cells in much the 
same way as the orig­
inal virus. Unlike the 
original, Iwwever, 
the mutants are not 
kthaL to T cells. Cells 
already occupied by 
mutantforms may be 
protectedfrom sub­
sequent infection by 
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virus replication alone from that of cell kill­
ing, by comparing the effects of our killing­
variety virus to our now-mutant virus," 
Ratner says. 
More specificaJly, Ratner and his col­
leagues are using the mutant viruslkilling 
virus comparison to look for cellular pro­
teins that might be involved in cell killing. 
'There are a number of proteins - some 
that we know about and probably some 
that we don't know about - that are made 
by lymphocytes and kill lymphocytes," 
Ratner says. 
Ratner speculates that if researchers 
could identify such a cellular protein, they 
would eventually be able to engineer a drug 
that interferes with the production of that 
protein . "Our major goal is not to sort 
through the chemistry shelf for drugs that 
inhibit viral replication," he says. "Rather, 
by learning what structures are involved 
in killing lymphocytes, we'll have a way 
to actually design drugs based on those 
structures. " 
A former research fellow under Gallo 
at the NCI, Ratner has made several sub­
stantial contributions to frontline AIDS 
research . He was one of 19 individuals 
responsible for initially cracking the virus ' 
genetic code, and one of the first research­
ers to produce its biologically active 
molecular clone. 
Although he works so closely with the 
virus, Ratner is not worried about catching 
AIDS. "AU of the evidence suggests that the 
way we work with the virus is very safe," 
he says. "Nobody who's ever worked in an 
AIDS research lab has ever developed 
antibodies to the virus." 
In the long run, man's battle with AIDS 
may actually serve to sharpen his mind for 
the larger war against all microbes. "I think 
we're going to get a lot of information about 
virology in general from this, because there's 
never been this kind of intense research on 
one virus," Ratner says. "More has been 
done in the last two years on this virus than 
has been done in the last 40 years on the 
polio virus. By studying one virus extremely 
intensely, we're actually learning more 




His decision to resume his career in 
surgery led him in 1936 to Washington Uni­
versity School of Medicine, where he was 
appointed a fellow in neurosurgery under 
Ernest Sachs, M.D., who was chief of the 
neurosurgical service and held the first aca­
demic appointment as professor of neuro­




was to stay just 
one year, 50 
years later 
Schwartz is still 
here. 
Schwartz's 














one of the 
mostes­
teemed neurosurgeons in the world . He has 
received every major honor from his col­
leagues, who recognize him for his scholar's 
mind, his numerous clinical contributions 
and advances and particularly for building 
one of the great neurosurgery training programs: 14 of the 45 resi­
dents Schwartz trained in his 28 years as department head have 
gone on to direct their own training programs. 
F rom his residents, he demanded excellence. The almost impossibly high standards he set for them, however, were no higher than those he set for himself. Colleagues and 
tormer residents alike describe him as a dedicated physician and 
perfectionist in patient care. 
"In his work habits, his day-to-day activity, there is a painful 
attention to detail and an integrity that characterizes his practice of 
medicine and his way of life," comments Sidney Goldring, M.D. , 
who trained under Schwartz in the early 1950s and succeeded him 
as professor and head of the Department of Neurological Surgery. 
Goldring has written of Schwartz, "He demanded exceJJence 
from his men, and the rigors encountered by his residents in 
meeting those demands have become legendary." 
Schwartz describes himself as a "tough taskmaster." Of his 
trainees he says, chuckling, "They'll probably call me all kinds of 
names and then they'll probably say that they love me as much as I 
love them." 
Robert King, M.D., one of Schwartz's first residents, 
laughingly admits that some people would describe Schwartz 
as "more than tough . But there was never any question that 
his concern was for your own development and for the pa­
tient's good. And he was fair," King adds. After completing 
his residency, King went on to become Schwartz's first faculty 
appointee, leaving the medical center in 1957 to become head 
of the neurosurgery program at Syracuse University. "The 
likelihood is that I've translated into our program and into 
my own life many things from him that I don't link directly 
back to him. His indirect persuasions can be very, very 
powerful." 
In a 1974 address to the Congress of Neurological Surgeons, 
Schwartz spoke of his almost paternal feelings toward his trainees, 
quoting a colleague's words about family: " 'It is with our chil­
dren that we have the unusual opportunity to help them attain 
responsible adulthood and take their active place in society. .. . 
They should know our love where love is not indulgence and giv­
ing in, but is to a great degree discipline, where we care enough to 
want them to grow up right.' " 
He continued, "Better than any phrase I might devise, this 
expresses my own feeling toward those young men whom good 
fortune has sent to my program. I have demanded much of them 
but have wanted much for them. Their successes have been my 
reward and my job." 
Residency under Schwartz was difficult, recalls William E 
Collins, M.D., who also trained with him in the early 1950s and 
now heads the department of surgery at Yale University Medical 
Center. 
"I got so upset when he was upset with me one time, 1 told him 
... that 1 not only didn't have to be a neurosurgeon, I didn't even 
have to be a doctor. I could be something else if he thought I was 
that bad, but I wanted another opinion," Collins recounts. "His 
reply to me was, 'Don't be foolish. I'll tell you when you're not 
good enough to go on,' and he walked off. That," he laughs, "was 
a compliment." 
Today, Collins considers Schwartz a close personal and pro­
fessional friend. "He has been probably more supportive of me 
than almost anybody I know and has helped tremendously to 
allow me to develop the two programs that I've set up." Accord­
ing to Collins, one of Schwartz's very striking traits is his 
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lems, develop programs and decide which direction to go in 
the profession. 
Goldring agrees. "He puts a tremendous amount of emphasis 
on loyalty and is extremely loyal to those he respects and 
works with." 
Schwartz's neurosurgery training program's success, many say, 
is due in large part to his emphasis on research. The residency 
program he set up in 1946 was one of the first in the country to set 
aside a substantial block of time solely for research. Neurosur­
geons trained by Schwartz, therefore, had an attribute that most 
other residents lacked - a background in either basic or clinical 
research on the nervous system. 
As Collins points out, "They not only had a very careful 
instruction in surgery - to the point that it was almost impossible 
to please him completely - but at the same time, a very thorough 
instruction in basic anatomy and basic pathology and then an 
opportunity to use investigative techniques to study the nervous 
system. That combination was extremely rare in any of the 
neurosurgical programs at that time." 
"He set extremely high standards for people going through that 
program, so that he required not only to know what you should 
do, but why you should do it. And that ... was a change .. . 
recognized throughout the country, so that the major training pro­
grams really started to foJlow his lead . 
"He really was the pivotal point as to the change that occurred 
from developing a person who was a technical surgeon to one who 
was an academic neurosurgeon." 
Schwartz himself takes a modest view. The values that 
he tried to instill in his residents, he says, were those of the 
greats of medicine: William Halsted, the Johns Hopkins sur­
geon who trained numerous physicians and whose philosophy 
dominates the profession even today; Evarts Graham, head 
of surgery at Washington University and his very close 
friend; another good friend, Edwin Churchill, professor of 
surgery at Harvard; and many others from the rosters of 
medical history. 
"They all had the concept of providing for their trainees 
the facilities and the atmosphere to think for themselves, to 
discipline themselves as far as hard work and the care of the 
patient was concerned and to push the frontiers forward 
and learn more about the field in which they were working," 
Schwartz says. 
"And to do that , they made it possible for their men to learn the 
techniques as well as the art of medicine - of surgery - and the 
ability to seek out answers, both in the clinic and in the laboratory. 
And all of these wonderful individuals - almost all of them ­
had somewhere along the line taken the time to pursue basic 
scientific work." 
MOSt of the great contributors to surgery and neurosurgery, Schwartz knew personally. His life, he says, has been "a constellation of fortuitous events." 
"Environment, luck - good or bad - and fortuitous 
events make us what we are," says the man who in 1924, at the 
age of 15, entered Princeton University knowing that he wished 
to become a neurosurgeon . It was at Princeton that Schwartz 
conducted his first brain surgery on the earthworm, " the 
lowliest creature." 
Because of its ability to regenerate itself, the earthworm 
was an ideal subject for Schwartz, who was interested in 
learning the process involved in regeneration. He began to 
study its nervous system, removing the main cerebral 
ganglia, the nerve centers. " I became 
fairly adept at removing these ganglia 
and then watching them grow back," 
he recoJlects. 
Schwartz continued this research at Johns 
Hopkins School of Medicine, where he en­
rolled after receiving his bachelor of arts 
degree in 1928. There, he worked with 
anatomy professor Marian Hines. 
"She was certainly my guiding 
light," he says. "She had heard that I 
had done this work at Princeton and 
she asked me about it. She thought I 
ought to continue it. That began a life­
long relationship. She was a superb 
woman, one of the finest women in 
the world." 
Hines - as well as other prominent 
anatomists and biologists at Hopkins ­
greatly int'luen.'ed Schwartz, who during 
that period realIzed his lifelong interest in 
anatomy and the nervous system. At the 
same time, he was inspired by c,inicians; 
some of the greats of surgery and 
neurosurgery worked at Hopkins in 
those days. 
After receiving his Doctor of Medicine 
degree in 1932, Schwartz interned in gen­
eral surgery under Dean Lewis, M .D., 
then head of surgery at Hopkins, and 
passed instruments to Walter Dandy, 
M.D. Dandy 's renown as a neurosurgeon 
at least equaled that of Harvey Cushing, 
M.D. , who had been trained by Halsted 
and who in tum trained Dandy at Hop­
kins before joining the faculty at Harvard 
Un i versi ty. 
During the latter 
part of his internship, 
Schwartz was invited 
by Dandy to stay on at 
Hopkins. Although he 
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himself with "one 
foot in both camps, 
anatomy and neurosurgery." At 
that point he was "still waivering" and 
received a position as instructor in 
anatomy at Harvard. 
It was in Boston that Schwartz and 
his "very attractive, very bright" medical 
school classmate, Edith Courtenay 
("Reedie") Robinson , were able to marry. 
Back then it was "very rare, almost unheard 
of," for a medical student or resident to 
marry. But for Schwartz, marri age to 
Reedie was clearly the most fortuitous 
of eve nts. 
"She is the most fortunate thing that ever 
happened to me," he says. "From her, I sub­
sequently realized how vital it is. . to 
have a wife who can not only speak the same language, but more 
important, can understand and sympathize, worry, cheer you up 
and help you to maintain your own sanity and a certain 
amount of equan imity. 
"She has equanimity in tremendous amounts and has been 
a tremendous factor in everything I've done." EJ ith Robinson, 
MD. , is a clinica l assistant professor emeritus of pediatrics at the 
School of Medic ine. 
Of the sti nt at Harvard, Schwartz has said, 'Those were three 
very good years. indeed a happy time. " H.c decided, however, 
to return to clinical work , and that was how Schwartz ended up as 
Sachs' fellow at Washington Universit y. 
hose were the formati ve days of neurosurgery at 
Washington University School of Medicine and else­
where. The SI. Louis program, like all neurosurgery 
programs then, was not formalized. The fi rst specialty board, the 
Amer ican Board of Neurosurgery, and specific requirements for 
certifica tion were established during World War II. 
"Until then, the requirements were very vague, " Schwartz 
explains. "If the chief of the service that you'd been working on said 
you were okay to take the boards, well, that was all that was needed." 
At Washington University, the Schwartz's came into daily contact 
with people who since have become institutional cornerstones: 
Phillip Shaffer, Carl and Gertrude Cori, JO(; Erlanger, George 
Bishop, Evarts Graham, James O'Leary and many others. These 
early contacts, which developed into warm friendships, were possi­
ble because the school was smaller then, Schwartz comments. 
"In SI. Louis in those days. it was easy to get to know other 
indiv iduals in other departments on both sides of the street, the 
pre-clinical side and the clinical side ... The competition along 
with camaraderie was there ; likes and dislikes were manifest. But 
nevertheless, it was relatively easy to get to know people and to 
exchange ideas." 
In particular Schwartz remembers IUIlchtime discussions in 
which faculty from both sides of the street would eat lunch to­
gether and talk about thei.r experiments. 
Schwartz found time for those lunches, but it wasn't easy with 
the work load he had under Sachs, "an extremely tough task­
master. There were no nights off, there were no weekends off, 
there were no days off. You were expected to meet the professor at 
6 or 6:30 in the mornint.' and then make a quick rou nd before 
going into the operating room. We did all the x-rays ourselve, ­
the air injections, posi tioning the patients and so on - things that 
we don't do anymore. 
"After operating, Dr. Sachs would usually go to his office 
downtown at the University Club building, or he'd stop at the lab 
office across the street and dictate hi s notes and then go down­
town. Meanwhile, we made rounds and took care of the chores. 
When he'd come back in the late afternoon, at 5:30 or 6, we'd 
make rounds again. And if there were new patients who had come 
in, we'd have to work them up and dictate the notes, write the 
orders and then start all over aga in. That was just the way it was." 
At the time, the only neurosurgery lab was a pathology lab that 
Sachs supported with his own funds. Although Sachs would have 
preferred Schwartz to help section and examine tumors in the 
neuropat hology lab, Schwartz gravitated to the lab of neurophys­
iologist George Bishop. 
"Those of us who were interested in neurophysiology and that 
kind of research worked with Bishop in his lab on the eighth floor 
of McMillan," he remembers. " We worked up there on all our 
experimental work daily, by his good grace, reall y. 
~; " 
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"We were all rdat ivdy young. Of course, Dr. Bisllop wa~ many 
stages beyond u~. but he wa., very. very happy to have people 
working with him. He was a tough investigator, but a damn good 
one. and a superb mentor. We were very lucky." 
t Over tIle years. Schwartz 's projects yielded a number of sign ifi­
cant advances. With ~mother fell ow, Alan Kerr, he achieved the 
first direct recording of electrical act ivi ty from the exposed human 
~. brain in the Un ited States. Using a cathode ray oscilloscope that 
Schwartz built and sil ver ball electrodes, they were able to record 
thi s activity in the brief five mi nutes Sachs allowed them. 
" It was so amateurish it's laughable, when I thin k back." he 
says. "compared to just a few years later, and particularly now. 
But back then, live nunutes was pretty generous because Dr. 
Sachs was worried and so were we. His feeli ng was 'You 're 
wasting ti me here. YOll have the patient '~ brai n ex posed and you 'd 
better be doi ng something for the palien! instead of fooling around 
with this business.' " 
',-.,~ 
..,. 
Later. when Schwartz was at City Hospital, he conducted one of 
.. 	 the first randomized studies in neurological surgery on the effect of 
lu mbar puncture in reducing intracranial pressure in severe head 
injuries. 'There was a question whether every pat ient with a head 
inju ry should have a lumbar puncture . . Some people thought it 
would be dangerous, actually, if there waS too much pressure up 
above. so that was why we rail th is series" The study concluded 
that those cases could be handled without repeated spinal pu nctures. 
H Also at City Hospi t.11, Schwartz. c'-'veloped medullary trac­
totomy, an operation for intractable, or unrelieved, pain. The oper­
ation involves putting :' lesion in the medulla, a part of the brain 
stem, to interrupt pain pathways ancl relieve severe facial pai n. 
Though it 's no longer necessary, althe time it was "a pretty good 
operation. and it helped to elucidatc some of the anatomy" of pain 
paths through the brain stem. 
After World War U, he became enchanted with cervical 
cordotomy, wh ich he also developed, to abolish intractable pain at 
a high cervical level. The procedure elill1 inate~ pilin in the lower 
extremit ies, by operat ing in the neck rather than the brain stem. 
; ­ ...waris ab reeding ground for surgeons," Schwartz has 
said . "Whether we like it or not. we have to admit 
that for surgeons the experience -the treatment of 
wounds, treatment of iniect ion. the basic things one could learn 
about the physiology of the engine, the physiology of various 
organs - this is an experience which I think should not be over­
looked. Not that radvocate war as a part of training. It's a disas­
trous sit uation. But nevertheless, the experiences gained in war 
can be put to good use." 
In 1941. Schwartz joined the medical unit affiliated with Wash­
ington University and Barnes Hospital as assistant chief of the 
surgica l service. He was fortunate in his a~signments, he says, 
because they allowed him to learn and to contribute to the knowl­
edge of neurosurgical hand li ng of wounds to the head and nerves. 
Ln Afri ca, he encountered trying times. His equ ipment had been 
sunk, making it. of course, diffic ul t to operate. Yet he managed. 
"We ~tole some equipment." he laughs. " Until we got that. I 
carried a cW'ctte alld a rongeur my wi fe sen t me. And we had a 
bayonet forceps, but we did not have a cautery; we did not have 
clips. We had a drill that we stole. In most cases, the sku ll was 
already part ially opl'n from the wound, and then with a rongeur 
you could en large the hole." 
T he hot cautery they devised is " incred ible in this day and age. 
We used an alcohol lam p next to the operating table and when we 
got a bleeder that was too smal1 ro tie off. 
well we'd use the foreep~ - tum around, 
heat the bayonet until it got hot and then 
touch the bleede r. " 
Despite the hardships in Africa. 
Schwartz maue <;ignificant contributions 
and, in fact, was responsible for changi ng 
mili tary procedure on how to tre.1t injuries 
to the head and nerves. Policy had been to 
leave con taminated head wounds open to 
drain . That led, however, to increased infec­
tions, hemiations of the brain and a high 
morta li ty rate. SchwartL and his team 
learned that the death rate could be tre­
mendously reduced by cleaning wounds 
thorough ly and Llsing prec ise surgcry. 
The same held true for nerve injuries. 
Under Schwartz , the policy was to debride 
nerve wounds, permi t them to heal ,md (hen 
lhree to four weeks later operate on the 
nerve. That approach bettered soldier., ' 
chances of recovering function. 
"There were contaminated wounds. you 
see, because in the African campai!!n evatu­
ation was so bad we'd get patients up to sev­
eral days after they'd been wounded before 
anything 
was done for 
thtill . And 




wou ld have just 
cleaned up a 
little and left 
open to drain. 
But we fonnd it 
~ tft;#~ )crf;L 
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was ~l 10 operate on 
th m, cut out all the dam­
aged ti ssue and th n close 
them up. So that necame the 
general policy in Africa." 
fter Africa. Schwartz ~erved in 
Algiers, Italy and France. Just before 
his discharge, he completed a brief 
stint as chief of neurological surgery at 
Kennedy General Hospital in Memphis in 
1945. That year he wa!> awarded the mili ­
l<lry 'S prestigious Legion of M rit , and in 
1946 returned to Washington University, 
where Evarts Graham named him professor 
and heal! of neurological surgery. 
This. Goldring has said, began the phase 
of hi~ life when most of American medicine 
believes Schwartz made his greatest con­
tribution, training neurosurgeons. Goldring. 
in writin!!, about Schwartz. has noted, "he 
has always de-( mphasized the role of the 
teacher, arguing that it is of firs t importance 
to ' pick a good man; the reafter h learns, 
you don't teach him.' i . bel ieve that 
in his modesty he tells but half the story. 
Equally important i, the fact that the pro­
gram director cares." 
Although his residem:y training program 
was Schwartz 's most con~uming interest as 
departm nt head. he has served steadi ly 
as a neurosurgical consu ltant to tlw Army 
and th Veterans Administration . His most 
acti ve period as a consultant wa.., dllring the 
late 1960$ when, a., ncurol>urgical cOl1sulwnt to the Slirg on 
Genera l. he travck:d to Vielnam to observe neuro\urgery in 
.. .the held. 
Al~o, from 196. 67 he tuok on the position of acting head of 
the Department of urgery and acting surgeon-in-chief at Barnes 
Ho~pila l in addition to his responsibili ties as neuro,urgery head 
,md nellro~lIrgcon - in - l' h ief at Barnes, Chi ldren's und Jewi~h 
ho~pitals. 
In 1970. be was named Ihe Augu~1 A. Busch Jr. Pnlf~ssor of 
cu rologicaJ Surgery and lour years laler stepped down as head or 
the department. Rather than slacken his pace, Schwanz chose to 
use his extra lime to begi n new projects. 
H became editor of the prestigious }OIlI'f/<1{ (~INeilro.\1/rgl!ry in 
1975. ostensibly for three year~. ine yea rs later. the job - a 
demanding one - was turned over to his former student, Collin5. 
Schwartz aJ. 0 was instrumental in establ i~hing the craniofacial 
reconstruction program at the medical center in 1979. Accord ing 
to the program director Jeffrey Marsh, M.D. , "If it had not been 
for him and his willingness to not only lend his intellectual and 
~p iri tual support , hut to be physically involved a~ the ncurosur­
gl on and to spend many long hOllrs doing thal- ,on of devdop­
Illg a whole new career at the end of hi, career - J th ink we 
would have had great trouble gelling otf the ground ." 
Schwartz himself says he became "cnamored" with craniofa­
cial work , mw:h prefernng ilta "ordinary tumors." He stopped 
serving as neurosurgeon for the craniofacial cases about two years 
ago. but remains interested . 'Ii) this day, Mar h poi nl~ OUt , 
Schwartz ~ends him articles related to craniofat: ial reconstruction 
and follows up Illl favorite patients when they come in 
lor checkups. 
, chwnrtz's Iate~t project is the Vietnam '-lead Injury study, the 
mo"t comprehensive study ever conducted of penetrating head 
i l~uries. He i ~ one of fi ve members of a direelOratr..: that owrsces 
thi~ Department or Defense qudy. 
The nngoing 'mldy. which began in 191)1 , compares .-20 brain­
injured veterans to 85 uninjured veteral1l>. Data collected from the 
study have demonstrated improved neurosurgical and neurological 
managemcnt of bmin injuries and illustrated how brain injuries 
affect tl inking. Ill~mory and mood . Researchers are now analyz­
ing data for in~ights into cogni tive disability, social adjustment, 
mood, intelligence ,md mher p ychometric variables. 
Schwartz has received virtually every honor in neurosurgery. 
including the Distinguished Service Award from both the Amcri­
can Board of Neurological Surgery and the Society of Neuwsur­
gl:!ons, the Harvey Cu~hing Medal from thc American Association 
of Neurological Surgeons und eJeclion in 19H5 a~ honorary pre~i ­
dent of the W()rid Federalion of Neuro~urgical Socidie . He i a 
I1lcmbn or thl:' Joh ns Hopkin" Society of Sch()l~ and i~ profi l d 
in "Leader~ in American Medicine," a videotape made for the 
AOA National Library of Medicine. 
JIe has held Illany appointments. alllong Ihem chairmanship of 
lhe American Board of euroiogical Surgery. pw,idency of ::l ll the 
major nellro~urgical societies, und vice presidency of the Ameri­
can College Df Surgeon~ and the American Surgical A~s\lc i ation . 
In 1981 hi~ colleagues and former rc idents cstabli~hed the Henry 
G. Schwartz Lecture hip, now delivered annual!. at the School of 
Medicille. 
"As of July I, I completely qU it operating." Schwartz says. He 
is a fam il iar sight in the halls. with his distinguished," hite hair. 
tall !)parc frame and a walk that he sort of !Lans into. a. though 
he's impatient to get to his deqination. Hi ~ interest. he huckles. is 
"survi ing - sur iving day to day" Rut, he add." "I ~t iII do a 
litt le work around here. ,. • 
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Alumni Usher in New Loan Program 

wenty-Ilve students and 
their benefactors 
ushered in the new 
Medical Scholars Loan Pro­
gram by wining and dining to­
gether tbis past September at 
SI. Louis' Racquet Club East. 
The program was estab­
lisbed last year in an effort to 
help students meet the high 
cost of medical education with 
interest-free loans, thereby up­
holding tbe long-standing prin­
ciple that no student should 
have to torgo medical educa­
tion at Washington University 
because of fi nancial duress. 
Alumni and friends contrib­
uted a total of more than 
$36,000 to the program, which 
was matched by the Washing­
ton University Medical Center 
Alumni Association LO estab­
lish 25 interest-free student 
loans. 
Summing up donor 5enli­
ments, Henry G. Schwartz, 
M.D.. August A. Busch Profes­
sor Emeritus of Neurosurgery, 
explained his reason for estab­
lishingone of I I named Joans: 
"These students need money to 
help them get through school; 
they're all broke. It's important 
for us Lo make it possible for 
good candidates to come here 
and SLay here." 
The Alumni Association's 
Executive Council, which met 
prior to the cocktail recepuon 
and dinner. announced its in­
tention to do just that - by 
matching this year's coming 
donations to the program up to 
$50,000. Presenting a check for 
$36,914 to Samuel B. Guze. 
MD., vice chancellor tor medi­
cal affairs. Donald G. Sessions, 
MD '62, president orthe 
Alumni Association, described 
his group'S contribution as "a 
gift l"hat can only match the in­
terest and concern of aJwnni 
towards their medical school ." 
1bp: Washingtoll University jas/rifm iksigll students entertain 
spouses dlUing the Executive Cc,mci1 meeting. Cmter: Tara Ann 
Rumbarger and her donor, Mitchell Yanow, enjoy dinner oJ the 
Racquet Club East. Bottom: Man,in E. Levul alld senior studelll, 
Robert W. 1Olml, enjoy each other's company aJ the Medical 
Scholars LoaJI Program DinJler. 
In addition to formal recog­
nition. the evening's events 
provided donors and students 
a more infomlaJ chance to 
meet. Those students who 
received namcd loans wel­
comed the special opportunity 
to meet and thank their donors 
one-on-one. 
Named loans established 
under the progranl were made 
possible by the Dr. Joe M. 
Boyles Memorial Ll,an Fund, 
established by Mrs. Joe M. 
Boyles; the Dr. and Mrs. 
Robert C. Drews Loan Fund; 
the Dr. and Mrs. Marvin E. 
Levin Loan Fund; the Loan 
fund in honor of Dr. Eli Robins 
and Dr. Samuel Guze, estab­
lished by Dr. Thomas F. 
Richardson; the Dr. and Mrs. 
Henry G. Schwartz Loan Fund; 
the Dr. and Mrs. William L. 
Topp Loan Fund; the Dr. and 
Mrs. Mitchell Yanow Loan 
Fund; and the Washington Uni­
versity Medical Center Alumni 
Association Loan Fund . 
Annual programs chairman 
Robert C. Drews, M.D. , who 
spearheaded the loan program 
fundi ng, concluded the short 
program that followed dinner 
by wishi ng the students the 
best for the future and assuring 
guests that the students "can 
be confident that they arl 
achieving the best. Washington 
University is one of the best 
because it has one of dle best 
student bodies." 
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Free-interest loans aid seniors 

throllgh final year 

'The fact that alumni 
have donated money 
to help us out has 
really boosted student 
morale." 
, , he mo t important 
thing is not to get 
bored with your job," 
Barbara M. Scavone, M.D. ' 87, 
says of medicine and of life in 
general. "No matter how much 
work you have or how little 
sleep you get, you have to look 
at it as fun, or you'll never 
survive," she says. 
Taking time to relax and 
pursue outside interests off the 
job is one way to avoid bore­
dom on the job, according to 
the School of Medicine sen ior 
from Glen Ellyn . Il linois. " If 
you live, dri.nk and eat medi­
cine. you're going to burn out," 
she remarks. "1 find that I'm 
much more enthusiastic about 
my work when I put aside an 
hour or two each day to sew or 
read a good book." 
Finding the time and place 
tor her favorite extracurricular 
activity - the piano - is diffi­
cult at times, but she practices 
at the student dormitory, Olin 
Hall , whenever she can. 'The 
piano's not exactly the IYpe of 
instrument you can carry 
around with you ," she says. "I 
realJy njoy sitting down at my 
mom's piano when ['m home." 
Scavone has been hammering 
ivory since the age of six, but 
her musical talents are by no 
means locked to the keyboard. 
She sings in her mother's 
church choir on Christmas and 
has sung in the School of 
Medicine's class show. She 
laughingly admits that her ath­
letic abilities leave something 
to be desired , even though 
she plays intramural soccer 
on "the worst team in the 
whole school." 
Scavone is one of 25 chool 
of Medicine students to benefit 
from the Washington Univer­
sity Medical S holars Loan 
Program. Hers is one of three 
named loans established by 
Elsie Boyles in memory of her 
late husband , Joe ~t Boyles, 
M.D. ' 30. "We're all carrying 
such a huge amount of debt 
these day that an interest-free 
loan like this is greatly appre­
ciated," Scavone says. "The 
fact that alumni have donated 
money to help liS out has really 
boosted student morale." 
Scavone, who plans to start 
a residency program in internal 
medicine next fall , came to 
Washington University from 
the University of nt inois at 
Champaign-Urbana, where she 
majored in biology and psy­
chology. Although she de­
scribes her fir t two years at the 
School of Medicin as "too 
many lec tures and too much 
memorization," she found her­
self really loving her third year 
on the wards. In addit ion to en­
joying the interaction with pa­
tients and freedom to organize 
her own time, Scavone finds 
most of the attendings willing 
to take extra time to explain 
things. "It's that e tea five min­
utes here and there that makes 
the dit'fercnce ," she explains. 
Scavone has selected inter­
nal medi ine as her specialty 
area because it is somewhat 
less focll sed than other spec ial­
ties, allowing her to "keep my 
sights on the whole picture." 
She is looking forward to a 
four-week extemship in Lon­
don, where sh will work in an 
intensive care unit. " It"ll be in­
teresting to compare the two 
phi losophies (of socialized and 
private medicine)," she says. 
" I' ll be spending about the 
same amount of time on the 
CCU unjt at Jewish H spital 
before I go." 
Scavone sees the di stribu­
tion of health care as the singlc 
most important challenge fac­
ing her generation of physi­
cians. "A dichotomy of care is 
developing between the rich 
and poor," she says. 'For ex­
ample, this ci ty has two 
magnetic r 'onance imaging 
facilit ies - one at the VA and 
one at Barnes. Yi t there are 
people coming into the VA who 
are suffering from TB and can­
not even alford to eaL W hat 
good is that technology to us, if 
we can't even solve endemic 
TB? We need to keep in mind 









hen he was in fo urth 
grade, Anthony C. 
Griffi n, M.D. '87, 
wanted to play the drums. His 
parents couldn't afford to buy 
their son a drum set, however, 
so tbe young Griffin learned to 
play the trumpet on his cousin's 
coronet. He remembers his 
parents encouraging him to 
keep playing, even thougb, at 
one ti me, he wanted to quit. 
"They knew then that the 
trumpet was somctiling Jcould 
enjoy tor the rest of my life," 
he says. "From this I learned 
the value of nOllelting yourself 
quit just because you want to." 
lbday, more than a dozen 
years later, Griffin sti ll plays 
the trumpet , while pursuing a 
passion for medic ine that began 
almost as early as his first mus­
ical notc. His ini tial fascination 
with medicine stemmed from 
frequent childhood visits to 
doctors, hospitals and clin ics 
he made with his two asthma­
tic brothers. Once planted, his 
interest in mcdicine took root 
during bigb school when he 
participated in a science and 
health opportuni ties program 
sponsored by the Universi ty of 
Wisconsin , Madison . 
When it came time for him 
to graduate, the high school 
football star from Kenosha, 
Wisconsin, who had already 
accumulated college credit, 
was a prime candidate for col­
lege recruiters. Griffin was 
offered scholarships at several 
prestigious institutions, among 
them the School of Music at 
the University of Califomia­
Berkeley. He decided upon 
Brown Universi ty because the 
ivy league school placed 
more emphasis on education 
than athletics. 
During his freshm an and 
sophomore years as a premed 
at Brown, Griffi n played the 
receiving position on the foot­
ball team. And during his 
sophomore year, he played the 
tru mpet in a local jazz band. 
Now a senior medical student 
at Washington University, 
Griffin finds his soon-to-be 
alma mater si milar to Brown in 
terms of its high degree of per­
sonability and support from 
administration and fellow stu­
dents. He views his recent re­
ceipt of a named, free-interest 
loan as " testament to how 
concerned Washington Univer­
sity is in terms of its students." 
And he was impressed with the 
dinner that was held in con­
junction with the establishment 
of the loans. "They could have 
just handed out the loans and 
said , ' Here you go.' It was just 
another example of how Wash­
ington University is a first 
class place." 
Griffi n plans to pursue a 
career in plastic surgery, 
remaining in St. Louis for his 
residency. so that he and his 
fiancee, Colette, a native of 
St. Louis, can marry this Feb­
ruary. Surgery appeals to him 
because "it gives you the abil­
ity to intervene, to make direct 
applications to pathophysiology 
and obtain inuned iate personal 
gratification. " And he believes 
plastic surgery suits him be­
cause, "it is so diverse, you can 
do anything from a face lift to 
tendon repair to reconstructive 
surgery. It's also technically 
appealing because it's so 
sophisticated. " 
Gri ffin would like to some­
how contribute to medical re­
search, having already spent a 
year investigating the role of 
glucotrienes in hydronephronic 
rabbit kidneys through the 
M.D./Master'$ program at the 
School of Medicine. 
He 1110St definitely believes 
that programs such as the Med­
11 11111 
l~ll , /' 
ical Scholars Loan Program 
will encourage current students 
to be good alums. "It has to 
start somewhere," he says. 
"Alumni coming back, alumni 
giving is what keeps it all 'H was just another 
going. It's that continuity that's example of how Wash­
so important. " ­ ington University is a 
first class place. " 
0." (l1I(l ~40.· 
Glen F. Irwin, M.D. '30, 
was selected by the Wisconsin 
Bureau of 1i urism to have his 
color slide of a loon on the 
billboard advertising the 
tourism logan , "Escape to 
Wisconsin." Dr. Irwin's tide 
was chosen from 100 other 
slides submitted to the bureau . 
A retired surgeon, Dr. Irwin 
and hi ' wife, Jane, live on 
Planting Ground Lake, Wis­
consin , where they are active 
loon watchers. 
Cramer D. Reed, M.D. 
'41 has become director of an 
employee health management 
and fitness program called 
Health Strategies. A division of 
the Wesley Medical Center in 
Wichita , Kansa the program 
features employee health pro­
motion, cardiac rehabi li tation 
community health education 
and a 2,000-square foot fitness 
center. 
James H. Cravens, M.D. 
'43, has been elected to a 
three-year term as president 
and chairman of the nIinois 
chapter of the American 
Academy of Pediatrics. The U­
linois chapter is one of the 
largest in the academy, with 
more than 1,200 pediatrician 
members. Cravens has been a 
member of the Physicians and 
Surgeons Clinic in Quincy 
since 1948. He is al 0 a mem­
ber of the Academy 's commit­
tee on hospital care, Presid nt 
of the Swanberg Medical 
Foundation of Adams County 
Medical Society. Past-President 
of the Adams County Medical 
Society and the Downstate 
IlLinois Pediatric Society, a 
Diplomate of the American 
Board of Pediatrics and a Fel­
low in the Am rican Academy 
of Pediatrics. 
60.t; 
Oliver J. Biederman, 
M.D. '58 FRS recently ran 
his twelfth marathon. He is 
currently th physician in 
charge of the Kaiser Perma­
nente facility in Lan aster. 
California where he empha­
sizes heal th maintenance and 
physical fitness. 
C. Craig Tisher, M.D. '61, 
wa'! recently elected to the 
Council of the American Soci­
ety of Neph logy. 
Anthony E. Falhman, 
M.D. '64 is serving a one­
year term as president of the 
American College of Surgeons' 
Missouri chapter. 
Roger L. MeU, M.D. '65, 
was recently elected Vice-Pres­
ident of th Southern Merucal 
Association a 50,OOO-member 
voluntary association of pbysi­
cian'! dedicated to fostering 
scientifiC medjcine. 
Richard H. Weisbart, 
M.D., '65, was recently pre­
sented the Philip Hench Award 
by the A sociation of Military 
Surgeons of the United States 
for outqtanding contributions in 
the field of rh umatology and 
arthritis. A professor of medi­
ci ne at the University of 
Cali fornia Los Angeles, and 
chief of rh umatology at the 
Veterans Adminjslration Medi­
cal Center in Sepulveda, 
California, Weisbart is actively 
involved in human lymphokine 
research. 
Jerome H. Kaplan, M.D. 
'66, was recently named one of 
86 fellow by the American 
College of Radiology' Board 
of Chancellors. 
Wendy R. Eider, M.D. '76, 
FHS, i' in solo practice in 
rheumatology. She and her hu ­
band. Darry D. Dernfeld, 
M.D. '77. who is a urgeon , 
live in Yakima, Washington , 
with their three-and-a-half­
year-old daughter, Jessica. 
Faith B. HOlcoOlbe, M.D. 
'80, FRS, writes that she and 
h r husband, Fred Fiedoreck 
Jr., M.D., a graduate of Harvard 
Medical School. are thrilled 
with Lheir daughter, Elizabeth, 
wh ) was born January 31 st and 
"is already demonslrating 
a thirst for knowledge by 
ehewing on our journals." 
Robert W. Laakman, 
M.D. '80, FHS, is a partner in 
Radiology Associates P.A. in 
Little Rock, Arizona, where he 
live. with hi wife, Sheree, and 
children: Petl;. 3Yz and Anna, 
two months. 
Samuel D. Soule, M.D. 

'28, protessor emeritus of clin­
ieal obstetrics and gynecOlogy, 
died Oct ber 29, 1986, at the 
age of 82 . A devoted faculty 
member, alum and community 
member, Soule served as chair­
man of the Dean's Committee 
at the School of Medicine for 
five years; as historian, corre ­
pondent and reunion chairman 
for his medical class; as cbair­
man of the Alumni Relations 
Committee and as Vice Presi­
dent of the Alumni As ocialion. 
He also was an Eliot Society 
member lor many years. 
SouJe was on the staff of 
both Jewish and Barnes hospi­
tal , having served as chief of 
obstelrics and gynecology and 
president at Jewih . 
He contributed to more than 
75 publications in his field and 
was a member of the American 
Medical Association, tbe Mis­
souri Medical Association, the 
St. Loui . Medical Society, the 
American College of Ob telri­
cl.an and Gynecol gi ts, the 
Ameri an Fertility Soci ly, the 
American Society of Psychol­
ogy, the Academy of Science of 
St. Louis, the St. Louis Gyne­
cology Society ,md th Jewi h 
Federation of St. Louis. 
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Mixing Medicine and History 

. \ 
BY CANDACE O'CONNOR 
been discarded ," says Pearson, mmet E Pearson. M.D. 
emeritus professor of medical'30, is a great believer in 
history, who has lectured serendipi ty. "You do 
extensively in the United States one thing," he likes to say, "and 
and Europe on medical something else lurns out better 
than you had expected ," After history topics, 
The museum is also a tribute all, he stored one antique phy­
to the vision of Pearson, a sician's desk in his basement ­
.: 
and soon amassed a medical remarkable local physician 
history collection. Then he who chose to bypass life in the 
helped plan a medical lichool big city for a successful career 
for his hometown of Spring­ in Springfield. For more than 
50 years, this 1930 Washingtonfield, Illinois - and it provided 
the ideal framework for a University School of Medicine 
new medical history museum graduate has maintained a L. 
named. in hL .. honor, The private practice in internal 
medicine, while serving inPearson Museum. 
The 9-year-old museum such local leadership roles as 
Chairman of the Department pays tribute to the many physi­
of Medicine and President ofcians living and working in tile 
Staff at Memorial Hospital. upper Mississippi River basin, 
Along the way, as he modestly whose ingenuity and dedication 
admits, he has been personal have moved the field of medi­
physician to two Illinois gover­cine another haIting step tor­
nors, one of them White House ward. G leaming showcases in 
aspirant Adlai Stevenson. the large museum room, lo­
"Dr. Pearson is an elder cated on the SJU-Springfield 
statesman of Springfield'scampus. display some of their 
equ ipment. There are early X­
~-- ray tubes, ivory-handled bladder probes and 
intubation devices that saved the lives of 
't''''';' ,jzf 
children choking from diphtheria . A silver n 
double button, invented by a Chicago 
surgeon in the 18905, joined a resected in­
testine and sloughed off after healing. 
''I'm sure that those who have an interest 
in medical history are much more apprecia­
tive of the wonderful things we have, which 
have been bu ilt on those things that have 
medical community, held in 
high regard as a physician, teacher and 
community leader," says Jack Siefkas, 
former director of medical alumni and 
development programs, who met Pearson 
while working at SIU-Springfield. "Along 
31 
J. _ 
with being a role model, Dr. P arson also 
has shown a warmth and chann to everyone 
associated with him." 
As a founder and former president of the 
Sangamon County Historical Society. Pear­
son is deeply involved in historic preser­
vation. A few years ago, he and his wife, 
Mary, discovered a century-old agestop in 
nearby Clayville restored it and presented 
it to Sangamon Stale Universi ty He has 
long worked to give the Springfield area a 
broader view of itself. 'Everytrung used to 
be Abraham Lincoln here. People feel that 
nothing happened before Linc In came and 
nothing has happened sinc ," he says. 
But inevitably, he too has gotten caught 
up in Lincoln. In hi. museum, there are 
Jedg r pages showing Lincoln's purchases 
from a local drugstore. After careful re­
search , Pearson has formed his own opin­
ions about L incoln' health. Lincoln was 
meianchol.ic, covering up periods of depres­
sion by teUing jokes; he had indig tion , 
wruch was never fuIly diagnosed. Most 
controversial of all. Pearson says. Lincoln 
may have had venereal disease. 
Pearson was born in the hills of Thnnes­
see near the Miss! sippi rder. H is father 
ran a country store and the famjly farm, 
former ly a plantation; his grandfather was a 
Confederate Civil War veteran held prison­
er by the "damn Yankees" in Memphis. "It 
was still a 19th century way of life: no elec­
tricity. no water works. no trans rtation 
except horse-dra n vehi les" he says, 
Aft r a year at the University of Mis is­
sippi. he followed his brother to Washington 
University, where Pearson fini shed his A. B. 
in 1926. To earn money, he worked in the 
cafeteria at night, climbing the ladder from 
dishwasher to caEhier. During the summers, 
he supervi 'ed t ms of magazine ales men 
as they fanned out acro s the Midwest . 
Pursuing a lifelong anlbition. he moved 
on to the Washington University School of 
Medicine and an internship/residency at 
Barnes Hospital . The faculty was an emi­
nent group; two w n Nobel Prizes while he 
was th reo He remembers particularly his 
mentors David Barr, M.D.. Edmund Cow­
dry, M D. and most of all, Evarts Graham, 
M.D., for whom he did research into the 
medical side of lung disease. "Many of my 
professors now have portraits on prominent 
walls at Barnes Hospital; they were such 
great physicians," he says. 
Following medical school, Pearson used 
savings from his magazine job to finance a 
six-month trip to several famous European 
clinics. He admired the French treatment of 
nervous disorders and the German method 
of demonstrating patients, brought to per­
fect ion by Friedrich von Mueller, M.D. 
Out of training in the midst of the 
Depression, Pearson picked Springfield, a 
state capitol with a reliable government 
payroll , as a place to settle down, He had 
specialized in internal medicine "since you 
get a philosophical point of view along with 
the scientific one, a 'holistic' approach." He 
made a fortunate choice of sub-specialty: 
the treatment of allergy. " one had ever 
heard of it, .0 other doctors referred their 
patients to m ," he says. 
Then war xploded in the Pacific. Pear­
son had to leave his burgeoning practice 
and young family to spend four years at 
various military hospitals. A one-year stint 
as commander of a large hospital in the 
Philippines wa · the most harrowing. They 
cared for the Manila elite, includjng bishops 
and supreme court justices, along with 
wounded soldiers from the front lines just 
a few miles away. 
Back home, he took a job at Northwest­
ern University, only to decide within months 
that Chicago was "too big." He retumed to 
Springfield and soon had prominent patients 
in Governor Adlai Stevenson and, later, 
Otto Kerner. 'When Stevenson was running 
for the presjden , I was interviewed about 
his health ," he recal l . "I aJways gave him 
a good report· I thought he was healthier 
than Eisenhower... 
Before the 1968 state sesquicentennial, 
Pearson took on a fateful role as chairman 
o an flIinois State Medical S ciety commjt­
tee setting up a medica l history museum. 
They already had one item, a magnificent 
walnut desk, custom-made for a Chi ago 
physician just before the great 1871 fire 
destroyed his office. Pearson stored it in his 
basement, only to discover that funds for 
the museum would not vailable. 
But medical his tory had been Pear 'on's 
long-time hobby, During medical school, he 
belonged to a group of interested students 
who met to di cuss hi storical topic . On his 
way to Europe, he stopped at Joh ns Hop­
kins University and "sat at the feet" of the 
renowned William Welch, M.D., the first 
professor of medical his tory in the US. 
Once his interest was rekindl d , he 
started collecting - in earnest when space 
in the new medical school was assured. He 
acquired a campi Ie antique druo tore with 
a sheaf of prescriptions and 207 apothecary 
jars bearing such intriguing labels as 
"myrrha," "pulvis rhei," or "crocus." He 
.. ......also began his own collection , now on 
display, of mail disinfected by various coun­
tries llsing smoke fommldchyde or steam 
in an effort to stem epidemics. 
The museum, which will soon expand to 
two new locations, also serves Pearson's 
favori te purpose: a teaching forum for in­
terested sru medical students. Each year, 
some 10 percent of the student body studies 
medical his tory, writing papers on such 
topics as yellow fever epidemics or the late 
Chief Gray Eagle, a patient of Pearson's, 
who was the last Indian medicine man 
in minois. 
Pearson still can't resis t picking up an 
occasional museum piece. In their spare 
time, he and his wi fe travel or enjoy their 
four children and grandchildren. He shrugs 
off retirement. '" ve been thinking about it 
for 20 years," he says. "but I don't get 
around to accomplishing it. I guess I like 
what I'm doing." 
Outlook Gets High Marks 
.. 
..../.• 
More than 20 years ago, when Outlook was first 

published as an eight-page newsletter, Dean M.K. King 

wrote, "We will begin modestly in size and scope, 

hoping for a more expansive future. " 

, < 
At that time, he invited alumni and mem­
bers of the Schtx)1 of Medicine staff to send 
..*~. suggestions for the type of material to be 
1\ 	 contained in future issues, keeping in mind 
the publication's original goal: "to inform 
the staff, and also the alumni residing in 
Sl. Louis, of developments with which they 
are not already familiar." 
To determine how well Outlook has been 
meetjng its original goal and new goals as 
well, those responsible for Outlook once 
again solicited readers' suggestions - this 
time in the form of a four-page, mailed 
readership survey conducted last summer. 
One-hundred-and-eighty-five readers 
responded to the survey, which was mailed 
to a total of 500 randomly selected recip­
ients of the magazine. Of these respondents, 
36 percent were M.D. alums, 16 percent 
were former house staff, 13 percent were 
School of Nursing graduates, 10 percent 
were allied health graduates, 7 percent were 
health administration and planning gradu­
ates, 6 percent were faculty members and 
the remaining 18 percent included Ph.D. 
alums, M.S.T.P. alums, non-academic staff 
and students and their parents. 
These reauers gave Ollllook magazine high 
marks for overall quality and appearance. 
Sixty-seven percent rateu the overall quality 
of Outlook as excellent, and 28 percent 
~ 
rated it as good. The magazine was rated. 
even more highly for its appearance, with 
80 percent of the respondents marking 
excellent, and 45 percent good. At least 90 
.~' ,~ percent of the respondents gave Outlook 
good or excellent ratings for quality of 
writing, photography and illustrations. 
Outlook:\' coverage of basic research, 
clinical research and patient care was evalu­
ated as excellent or gooU by at least 80 per­
cent of the respondents, while more than 
half gave the magazine good or excellent 
ratings for its coverage of students, general 
issues in academic medicine, institutional 
additions, alumni, faculty or institutional 
changes, opinion and development. The 
publication's coverage of nostalgia and 
curriculum and education were rated as 
needing improvement, with more than one­
quarter of the respondents evaluating cover­
age of these topics as fair or poor. Survey 
results also included a significant number of 
written-in suggestions to provide more 
coverage of nursing and other allied 
health fields. 
Survey respondents marked feature 
stories as the section they read the most, 
followed by Newsbriefs, Class Notes, 
Alumni Report, Silhouette, Personal 
Outlook and Student Stage. 
Readers' enjoyment of Outlook appears 
to depend to a large extent upon its visual 
effect. Ninety-six percent of the respon­
dents marked that the color photographs 
and illustrations enhance the magazine, and 
53 percent admitted that these photos and 
illustrations usually entice them to read a 
particular story. The most frequently 
marked reason for reauing a given story, 
however, was that "it regards a topic that 
interests me." 
Outlook:~ readers appear to be satisfied 
with how often it comes out, with approxi­
mately 90 percent of the respondents 
marking that the magazine should continue 
to be published on a quarterly basis. 
Seventy percent of the respondents prefer 
feature articles that focus exclusively on re­
search and people at Washington University, 
while the remaining 30 percent would like 
Outlook to include stories about people 
and research outside the university. Almost 
three-quarters of the respondents, however, 
agreed that they prefer more and shorter 
stories per issue, so that they can see a 
wider range of topics. 
On the whole, the Outlook survey found 
its readers to be proud of the publication . 
Approximately 68 percent of the respon­
dents marked that they share the magazine 
with a friend or family member at least 
occasionally. 
As survey results indicate, Outlook has 
certainly come a long way from its humble 
beginnings, with major strides having 
been made in the last three years under the 
direction of former editor Suzanne Hagan. 
Those who continue to be responsible for 
the magazine's production hope to make it 
an even greater success in the future. 
Readers' suggestions for a greater variety of 
topics and more shorter stories have been 
well taken, and the importance of the publi­
cation's visual appeal also has been noted. 
Outlook's new editor, Kathy Will, who 
comes to the magazine from Northwestern 
University Medical School where she was 
associate editor of the alumni magazine, 
will be working hard to make Outlook even 
better with each new issue. 






,(nHSIlli\GTO'" t ':\IVEHsm' 'IIEDlCAlCEi\TER 
660 SOUTH EUCLID AVENUE 
rIE D:r CAL.. L. I BRARY 
SERIALS DEPARTMENT 
.BOX 8132 00000 
ST. LOUIS, MISSOURI 6:3110 
Glutamate, which is found in high concentrations in the brain, is a 
paradoxical molecuk, not only serving as a neurotransmitter and a major 
building block for the fomwtion ofimportant brain peptides and proteins, 
but also as a potential toxin. Studying the lekyU and Hyde properties of 
glutmnak are Washington University School ofMedicine's own Drs. lohn 
W. Olney and Madelon T. Price. See story, page 8. 
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